SKMLCK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S473 | Sugiyama | SHTN1 KIAA1598 | LGtLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADss |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| O00512 | S104 | Sugiyama | BCL9 | GLKNGAGNGAKGKGKRERsIsADsFDQRDPGtPNDDsDIKE |
| O14639 | S452 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | PtPsAEGyQDVRDRMIHRstsQGsINsPVySRHsYtPTTSR |
| O14950 | S20 | GPS6 | MYL12B MRLC2 MYLC2B | _MSSKKAKTKTTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| O14950 | T19 | GPS6 | MYL12B MRLC2 MYLC2B | __MSSKKAKTKTTKKRPQRAtsNVFAMFDQSQIQEFKEAFN |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | T141 | GPS6 | PPP1R12A MBS MYPT1 | IAEFLIGQGAHVGAVNSEGDtPLDIAEEEAMEELLQNEVNR |
| O14974 | T696 | Sugiyama | PPP1R12A MBS MYPT1 | EEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRS |
| O14974 | T700 | Sugiyama | PPP1R12A MBS MYPT1 | sQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRSTRTR |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O60749 | S119 | Sugiyama | SNX2 TRG9 | AVtPVtPttLIAPRIESKsMsAPVIFDRsREEIEEEANGDI |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O75128 | S1174 | Sugiyama | COBL KIAA0633 | LAAIRGHSGTCSLRKVAsSAsEELQSFRDAALSAQGSESPL |
| O76021 | S92 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | KIPSKELRVRLTLPHSIRsDsEDICLFTKDEPNStPEKTEQ |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04181 | T39 | Sugiyama | OAT | HSSVASATSVATKKtVQGPPtSDDIFEREyKyGAHNyHPLP |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06744 | T109 | Sugiyama | GPI | KINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLDKM |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08670 | T327 | Sugiyama | VIM | DALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMREM |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P13073 | S71 | Sugiyama | COX4I1 COX4 | HVKHLSASQKALKEKEKASWssLsMDEKVELYRIKFKEsFA |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18615 | S51 | Sugiyama | NELFE RD RDBP | ALKKQSSSSTTSQGGVKRsLsEQPVMDTATATEQAKQLVKS |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19105 | T18 | GPS6 | MYL12A MLCB MRLC3 RLC | ___MSSKRTKTKTKKRPQRAtsNVFAMFDQSQIQEFKEAFN |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | Y463 | Sugiyama | NCL | EKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsG |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P24844 | S20 | GPS6 | MYL9 MLC2 MRLC1 MYRL2 | _MssKRAKAKtTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| P24844 | T19 | GPS6 | MYL9 MLC2 MRLC1 MYRL2 | __MssKRAKAKtTKKRPQRAtsNVFAMFDQSQIQEFKEAFN |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25789 | T9 | Sugiyama | PSMA4 HC9 PSC9 | ____________MSRRyDsRttIFsPEGRLYQVEYAMEAIG |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35241 | S532 | Sugiyama | RDX | EERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40337 | S72 | Sugiyama | VHL | EEMEAGRPRPVLRSVNsREPsQVIFCNRsPRVVLPVWLNFD |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P40939 | T418 | Sugiyama | HADHA HADH | DRGQQQVFKGLNDKVKKKALtSFERDSIFSNLTGQLDyQGF |
| P41236 | T22 | Sugiyama | PPP1R2 IPP2 | AASTAsHRPIKGILKNKtsttssMVAsAEQPRGNVDEELSK |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S1098 | Sugiyama | MKI67 | PAARVTGMKKWPRtPKEEAQsLEDLAGFKELFQtPGPsEEs |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | S659 | Sugiyama | NASP | IEELKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsst |
| P49321 | S662 | Sugiyama | NASP | LKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsstsGF |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | T413 | Sugiyama | GDI2 RABGDIB | GtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFEE |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60900 | S175 | Sugiyama | PSMA6 PROS27 | DPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTV |
| P60900 | T173 | Sugiyama | PSMA6 PROS27 | KCDPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQ |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61978 | S417 | Sugiyama | HNRNPK HNRPK | DLAGsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITI |
| P61978 | S420 | Sugiyama | HNRNPK HNRPK | GsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITItGt |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62424 | T93 | Sugiyama | RPL7A SURF-3 SURF3 | RLKVPPAINQFtQALDRQTAtQLLKLAHKYRPEtKQEKKQR |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01082 | S2184 | Sugiyama | SPTBN1 SPTB2 | ssPIPsPtsDRKAKTALPAQsAAtLPARtQEtPsAQMEGFL |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06413 | T80 | SIGNOR|EPSD|PSP | MEF2C | TDMDKVLLKYTEYNEPHESRtNSDIVETLRKKGLNGCDsPD |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07021 | S106 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | LsDEIKEERKIQKHKTLPKMsGGWELELNGTEAKLVRKVAG |
| Q08AD1 | S1313 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sLNtGDNEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWE |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q12965 | T935 | Sugiyama | MYO1E MYO1C | VLQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAA |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13769 | S312 | Sugiyama | THOC5 C22orf19 KIAA0983 | GSVDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQ |
| Q13769 | S314 | Sugiyama | THOC5 C22orf19 KIAA0983 | VDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQLD |
| Q14247 | S113 | Sugiyama | CTTN EMS1 | DRMDKsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVD |
| Q14432 | S312 | Sugiyama | PDE3A | sssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKRG |
| Q14498 | S336 | Sugiyama | RBM39 HCC1 RNPC2 | LAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGR |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5SSJ5 | S225 | Sugiyama | HP1BP3 | QALKRELNRGVIKQVKGKGAsGsFVVVQKSRKTPQKSRNRK |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6PID6 | S19 | Sugiyama | TTC33 | __MASFGWKRKIGEKVSKVTsQQFEAEAADEKDVVDNDEGN |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q92766 | S1167 | Sugiyama | RREB1 FINB | AGTSKKRGRKRGMRSRPRANsGGVDLDssGEFASIEKMLAT |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96IZ0 | S162 | Sugiyama | PAWR PAR4 | PSARKGKGQIEKRKLREKRRstGVVNIPAAECLDEyEDDEA |
| Q96IZ0 | T163 | Sugiyama | PAWR PAR4 | SARKGKGQIEKRKLREKRRstGVVNIPAAECLDEyEDDEAG |
| Q96L92 | S51 | Sugiyama | SNX27 KIAA0488 My014 | AGNGGGGGGGPRVVRIVKsEsGYGFNVRGQVsEGGQLRSIN |
| Q99848 | S264 | Sugiyama | EBNA1BP2 EBP2 | KNQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRP |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9H1R3 | S107 | Sugiyama | MYLK2 | AEGsAGPPAALPQQTAtPETsVKKPKAEQGASGsQDPGKPR |
| Q9H1R3 | S143 | Sugiyama | MYLK2 | PGKPRVGKKAAEGQAAARRGsPAFLHsPsCPAIISssEKLL |
| Q9H1R3 | S149 | Sugiyama | MYLK2 | GKKAAEGQAAARRGsPAFLHsPsCPAIISssEKLLAKKPPS |
| Q9H1R3 | S151 | Sugiyama | MYLK2 | KAAEGQAAARRGsPAFLHsPsCPAIISssEKLLAKKPPSEA |
| Q9H1R3 | S158 | Sugiyama | MYLK2 | AARRGsPAFLHsPsCPAIISssEKLLAKKPPSEASELtFEG |
| Q9H1R3 | S159 | Sugiyama | MYLK2 | ARRGsPAFLHsPsCPAIISssEKLLAKKPPSEASELtFEGV |
| Q9H1R3 | S203 | Sugiyama | MYLK2 | HsPtDPRPAKAEEGKNILAEsQKEVGEKtPGQAGQAKMQGD |
| Q9H1R3 | S225 | Sugiyama | MYLK2 | KEVGEKtPGQAGQAKMQGDtsRGIEFQAVPSEKSEVGQALC |
| Q9H1R3 | S280 | Sugiyama | MYLK2 | CPPPPAPFPHRMVELRTGNVsSEFSMNsKEALGGGKFGAVC |
| Q9H1R3 | S287 | Sugiyama | MYLK2 | FPHRMVELRTGNVsSEFSMNsKEALGGGKFGAVCTCMEKAT |
| Q9H1R3 | S577 | Sugiyama | MYLK2 | QILLKKYLMKRRWKKNFIAVsAANRFKKIsssGALMALGV_ |
| Q9H1R3 | S586 | Sugiyama | MYLK2 | KRRWKKNFIAVsAANRFKKIsssGALMALGV__________ |
| Q9H1R3 | S587 | Sugiyama | MYLK2 | RRWKKNFIAVsAANRFKKIsssGALMALGV___________ |
| Q9H1R3 | S59 | Sugiyama | MYLK2 | PDPKKAPDPPTLKKDAKAPAsEKGDGTLAQPSTssQGPKGE |
| Q9H1R3 | S72 | Sugiyama | MYLK2 | KDAKAPAsEKGDGTLAQPSTssQGPKGEGDRGGGPAEGsAG |
| Q9H1R3 | S73 | Sugiyama | MYLK2 | DAKAPAsEKGDGTLAQPSTssQGPKGEGDRGGGPAEGsAGP |
| Q9H1R3 | S90 | Sugiyama | MYLK2 | STssQGPKGEGDRGGGPAEGsAGPPAALPQQTAtPETsVKK |
| Q9H1R3 | T103 | Sugiyama | MYLK2 | GGGPAEGsAGPPAALPQQTAtPETsVKKPKAEQGASGsQDP |
| Q9H1R3 | T175 | Sugiyama | MYLK2 | IISssEKLLAKKPPSEASELtFEGVPMtHsPtDPRPAKAEE |
| Q9H1R3 | T182 | Sugiyama | MYLK2 | LLAKKPPSEASELtFEGVPMtHsPtDPRPAKAEEGKNILAE |
| Q9H1R3 | T211 | Sugiyama | MYLK2 | AKAEEGKNILAEsQKEVGEKtPGQAGQAKMQGDtsRGIEFQ |
| Q9H1R3 | T224 | Sugiyama | MYLK2 | QKEVGEKtPGQAGQAKMQGDtsRGIEFQAVPSEKSEVGQAL |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQZ2 | S462 | Sugiyama | UTP3 CRLZ1 SAS10 | RAKIRRRGQVREVRKEEQRYsGELsGIRAGVKKSIKLK___ |
| Q9NUU7 | T467 | Sugiyama | DDX19A DDX19L | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UJU6 | T270 | Sugiyama | DBNL CMAP SH3P7 PP5423 | EQESAVHPREIFKQKERAMsttsIssPQPGKLRsPFLQKQL |
| Q9UMR2 | T468 | Sugiyama | DDX19B DBP5 DDX19 TDBP | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ80 | T377 | Sugiyama | PA2G4 EBP1 | LLQssAsRKtQKKKKKKAsKtAENAtsGEtLEENEAGD___ |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 6.923803e-08 | 7.160 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.393719e-07 | 6.194 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.368556e-07 | 6.077 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.483500e-06 | 5.829 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.635684e-06 | 5.579 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.118801e-06 | 5.506 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.118801e-06 | 5.506 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.545498e-06 | 5.450 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.467356e-06 | 5.460 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.697484e-06 | 5.328 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.447034e-05 | 4.611 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.344630e-05 | 4.630 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.817437e-05 | 4.418 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.037542e-05 | 4.219 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.244873e-05 | 4.084 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.251387e-04 | 3.903 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.483868e-04 | 3.829 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.509335e-04 | 3.821 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.646212e-04 | 3.784 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.232962e-04 | 3.490 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.448659e-04 | 3.462 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.923502e-04 | 3.406 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.808313e-04 | 3.236 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.954107e-04 | 3.225 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.473485e-04 | 3.262 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.805946e-04 | 3.236 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.970199e-04 | 3.224 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.356901e-04 | 3.197 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.371616e-04 | 3.196 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.211097e-04 | 3.142 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.211097e-04 | 3.142 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.474086e-04 | 3.072 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.278331e-04 | 3.033 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.098752e-03 | 2.959 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.348737e-03 | 2.870 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.845048e-03 | 2.734 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.184582e-03 | 2.661 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.184582e-03 | 2.661 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.184582e-03 | 2.661 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.184582e-03 | 2.661 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.537670e-03 | 2.596 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 2.668444e-03 | 2.574 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.799920e-03 | 2.553 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.747327e-03 | 2.561 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.810633e-03 | 2.551 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.593437e-03 | 2.444 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.642517e-03 | 2.439 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.835634e-03 | 2.416 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.307124e-03 | 2.366 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.665052e-03 | 2.331 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.677742e-03 | 2.330 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.506326e-03 | 2.346 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.739980e-03 | 2.324 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.924019e-03 | 2.308 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.946241e-03 | 2.306 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.280477e-03 | 2.277 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.416762e-03 | 2.266 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.949953e-03 | 2.225 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.875035e-03 | 2.231 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.980301e-03 | 2.223 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.986011e-03 | 2.098 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.752360e-03 | 2.111 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.674783e-03 | 2.062 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.303647e-03 | 2.081 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.346416e-03 | 2.078 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.861650e-03 | 2.052 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 9.148360e-03 | 2.039 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.069079e-02 | 1.971 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.064288e-02 | 1.973 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.085074e-02 | 1.965 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.085074e-02 | 1.965 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.133761e-02 | 1.945 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.123123e-02 | 1.950 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.105881e-02 | 1.956 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.081614e-02 | 1.966 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.149065e-02 | 1.940 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.154790e-02 | 1.937 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.194101e-02 | 1.923 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.202577e-02 | 1.920 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.185817e-02 | 1.926 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.241651e-02 | 1.906 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.241651e-02 | 1.906 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.255860e-02 | 1.901 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.288480e-02 | 1.890 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.317048e-02 | 1.880 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.448205e-02 | 1.839 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.389578e-02 | 1.857 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.449386e-02 | 1.839 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.478020e-02 | 1.830 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.478020e-02 | 1.830 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.491898e-02 | 1.826 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.521006e-02 | 1.818 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.536434e-02 | 1.813 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.625721e-02 | 1.789 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.584530e-02 | 1.800 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.625721e-02 | 1.789 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.767232e-02 | 1.753 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.767232e-02 | 1.753 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.794693e-02 | 1.746 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.795090e-02 | 1.746 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.952243e-02 | 1.709 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.978188e-02 | 1.704 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.948667e-02 | 1.710 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.952243e-02 | 1.709 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.049463e-02 | 1.688 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.084447e-02 | 1.681 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.184373e-02 | 1.661 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.215042e-02 | 1.655 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.215042e-02 | 1.655 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.350066e-02 | 1.629 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.358757e-02 | 1.627 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.360519e-02 | 1.627 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.363252e-02 | 1.626 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.468946e-02 | 1.607 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.468946e-02 | 1.607 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.468946e-02 | 1.607 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.452023e-02 | 1.610 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.576182e-02 | 1.589 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.545398e-02 | 1.594 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.486769e-02 | 1.604 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.631048e-02 | 1.580 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.646778e-02 | 1.577 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.879697e-02 | 1.541 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.913715e-02 | 1.536 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.839707e-02 | 1.547 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.879697e-02 | 1.541 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.839707e-02 | 1.547 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.761166e-02 | 1.559 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.850304e-02 | 1.545 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.851925e-02 | 1.545 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.851925e-02 | 1.545 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.761166e-02 | 1.559 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.887147e-02 | 1.540 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.042657e-02 | 1.517 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.066056e-02 | 1.513 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.286588e-02 | 1.483 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.286588e-02 | 1.483 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.286588e-02 | 1.483 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.286588e-02 | 1.483 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.286588e-02 | 1.483 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.398986e-02 | 1.469 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.398986e-02 | 1.469 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.353810e-02 | 1.474 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.269930e-02 | 1.485 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.321610e-02 | 1.479 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.398986e-02 | 1.469 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.394541e-02 | 1.469 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.269930e-02 | 1.485 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.402783e-02 | 1.468 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.402783e-02 | 1.468 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.506136e-02 | 1.455 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.506136e-02 | 1.455 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.506136e-02 | 1.455 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.599519e-02 | 1.444 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.669150e-02 | 1.435 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.744827e-02 | 1.427 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.810569e-02 | 1.419 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.838738e-02 | 1.416 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.838738e-02 | 1.416 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.844070e-02 | 1.415 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.844070e-02 | 1.415 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.967191e-02 | 1.402 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.972349e-02 | 1.401 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.408584e-02 | 1.356 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.147726e-02 | 1.382 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.442095e-02 | 1.352 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.442095e-02 | 1.352 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.443103e-02 | 1.352 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.549203e-02 | 1.342 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.592973e-02 | 1.338 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.597288e-02 | 1.337 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.636314e-02 | 1.334 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.666256e-02 | 1.331 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.690787e-02 | 1.329 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.789690e-02 | 1.320 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.789690e-02 | 1.320 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.391422e-02 | 1.268 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.391422e-02 | 1.268 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.441276e-02 | 1.264 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.441276e-02 | 1.264 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.983955e-02 | 1.302 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.983955e-02 | 1.302 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.873088e-02 | 1.312 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.443850e-02 | 1.264 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.443850e-02 | 1.264 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.343319e-02 | 1.272 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.067920e-02 | 1.295 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.461380e-02 | 1.263 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.599668e-02 | 1.252 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.750561e-02 | 1.240 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.752329e-02 | 1.171 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.302024e-02 | 1.201 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.302024e-02 | 1.201 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.614251e-02 | 1.180 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.641141e-02 | 1.178 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.641141e-02 | 1.178 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.641141e-02 | 1.178 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.641141e-02 | 1.178 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.641141e-02 | 1.178 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.641141e-02 | 1.178 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.260562e-02 | 1.203 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.789974e-02 | 1.168 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.641141e-02 | 1.178 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.731693e-02 | 1.172 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.856307e-02 | 1.164 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.752329e-02 | 1.171 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.641141e-02 | 1.178 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.317242e-02 | 1.199 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.956434e-02 | 1.158 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.614251e-02 | 1.180 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.856307e-02 | 1.164 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.092526e-02 | 1.215 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.491420e-02 | 1.188 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.005081e-02 | 1.155 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.164396e-02 | 1.145 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.210552e-02 | 1.142 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.291581e-02 | 1.137 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.302662e-02 | 1.137 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.533989e-02 | 1.123 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.533989e-02 | 1.123 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.533989e-02 | 1.123 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.629060e-02 | 1.118 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.629060e-02 | 1.118 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.745051e-02 | 1.111 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 7.745051e-02 | 1.111 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 7.745051e-02 | 1.111 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.745051e-02 | 1.111 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.797386e-02 | 1.108 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.797386e-02 | 1.108 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.797386e-02 | 1.108 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.797386e-02 | 1.108 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.797386e-02 | 1.108 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.093190e-02 | 1.092 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.151798e-02 | 1.089 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.151798e-02 | 1.089 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.170044e-02 | 1.088 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.131299e-02 | 1.039 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.131299e-02 | 1.039 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.679417e-02 | 1.014 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.679417e-02 | 1.014 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.444435e-02 | 1.073 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.795774e-02 | 1.009 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.072480e-02 | 1.042 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 9.725203e-02 | 1.012 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 9.359928e-02 | 1.029 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.286581e-02 | 1.032 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.128219e-02 | 1.040 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.131299e-02 | 1.039 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.849840e-02 | 1.007 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.028612e-01 | 0.988 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.034710e-01 | 0.985 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.041701e-01 | 0.982 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.041701e-01 | 0.982 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.041701e-01 | 0.982 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.046773e-01 | 0.980 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.046773e-01 | 0.980 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.073522e-01 | 0.969 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.093028e-01 | 0.961 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.093028e-01 | 0.961 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.093028e-01 | 0.961 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.093028e-01 | 0.961 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.097380e-01 | 0.960 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.125642e-01 | 0.949 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.312166e-01 | 0.882 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.312166e-01 | 0.882 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.312166e-01 | 0.882 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.312166e-01 | 0.882 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.452219e-01 | 0.610 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.452219e-01 | 0.610 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.452219e-01 | 0.610 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.452219e-01 | 0.610 | 0 | 0 |
| Tandem pore domain halothane-inhibited K+ channel (THIK) | R-HSA-1299287 | 2.452219e-01 | 0.610 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.569317e-01 | 0.804 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.569317e-01 | 0.804 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 1.569317e-01 | 0.804 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.350647e-01 | 0.869 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.070722e-01 | 0.684 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.070722e-01 | 0.684 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.070722e-01 | 0.684 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.070722e-01 | 0.684 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.070722e-01 | 0.684 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.070722e-01 | 0.684 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.070722e-01 | 0.684 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.442728e-01 | 0.463 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.442728e-01 | 0.463 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.442728e-01 | 0.463 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.442728e-01 | 0.463 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.442728e-01 | 0.463 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.442728e-01 | 0.463 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.442728e-01 | 0.463 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.442728e-01 | 0.463 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.442728e-01 | 0.463 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.442728e-01 | 0.463 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.442728e-01 | 0.463 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.442728e-01 | 0.463 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.442728e-01 | 0.463 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.442728e-01 | 0.463 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.442728e-01 | 0.463 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.442728e-01 | 0.463 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.442728e-01 | 0.463 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.442728e-01 | 0.463 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.132600e-01 | 0.946 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.680476e-01 | 0.775 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.372820e-01 | 0.862 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.372820e-01 | 0.862 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.372820e-01 | 0.862 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.372820e-01 | 0.862 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.585744e-01 | 0.587 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.585744e-01 | 0.587 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.130026e-01 | 0.947 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.130026e-01 | 0.947 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.030587e-01 | 0.692 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.030587e-01 | 0.692 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.631451e-01 | 0.787 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.329094e-01 | 0.876 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.329094e-01 | 0.876 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.329094e-01 | 0.876 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.542606e-01 | 0.812 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.542606e-01 | 0.812 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.905948e-01 | 0.720 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.905948e-01 | 0.720 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.395513e-01 | 0.621 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 3.102184e-01 | 0.508 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.102184e-01 | 0.508 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.303300e-01 | 0.366 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.303300e-01 | 0.366 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.303300e-01 | 0.366 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.303300e-01 | 0.366 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.303300e-01 | 0.366 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.303300e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.303300e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.303300e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.303300e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.303300e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.303300e-01 | 0.366 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.303300e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.303300e-01 | 0.366 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.303300e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.303300e-01 | 0.366 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.303300e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.303300e-01 | 0.366 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.303300e-01 | 0.366 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.303300e-01 | 0.366 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.303300e-01 | 0.366 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 4.303300e-01 | 0.366 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.444115e-01 | 0.840 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.769210e-01 | 0.752 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.193663e-01 | 0.659 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.193663e-01 | 0.659 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.636741e-01 | 0.786 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.770147e-01 | 0.557 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.252250e-01 | 0.902 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.512938e-01 | 0.820 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.164019e-01 | 0.934 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.839610e-01 | 0.735 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.610805e-01 | 0.442 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.610805e-01 | 0.442 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.610805e-01 | 0.442 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.255694e-01 | 0.647 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.149835e-01 | 0.502 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.873321e-01 | 0.727 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.873321e-01 | 0.727 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.798084e-01 | 0.553 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.798084e-01 | 0.553 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.798084e-01 | 0.553 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.512391e-01 | 0.600 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.885175e-01 | 0.725 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.145431e-01 | 0.941 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.883216e-01 | 0.725 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.264769e-01 | 0.645 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.530429e-01 | 0.452 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 3.530429e-01 | 0.452 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.104769e-01 | 0.387 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.104769e-01 | 0.387 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.104769e-01 | 0.387 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.104769e-01 | 0.387 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.104769e-01 | 0.387 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.050974e-01 | 0.297 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.050974e-01 | 0.297 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.050974e-01 | 0.297 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.050974e-01 | 0.297 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.050974e-01 | 0.297 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.050974e-01 | 0.297 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.050974e-01 | 0.297 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.050974e-01 | 0.297 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.050974e-01 | 0.297 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.050974e-01 | 0.297 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.453637e-01 | 0.838 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.578474e-01 | 0.802 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.578474e-01 | 0.802 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.046428e-01 | 0.689 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.046428e-01 | 0.689 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.044565e-01 | 0.516 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.215186e-01 | 0.655 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.215186e-01 | 0.655 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.215186e-01 | 0.655 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.424113e-01 | 0.465 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.424113e-01 | 0.465 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.908306e-01 | 0.408 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.908306e-01 | 0.408 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.908306e-01 | 0.408 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 3.908306e-01 | 0.408 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.903644e-01 | 0.720 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.249533e-01 | 0.648 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.213805e-01 | 0.493 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.213805e-01 | 0.493 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.213805e-01 | 0.493 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.739340e-01 | 0.427 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.739340e-01 | 0.427 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.579166e-01 | 0.339 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.579166e-01 | 0.339 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.579166e-01 | 0.339 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.579166e-01 | 0.339 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.342063e-01 | 0.872 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.452372e-01 | 0.610 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.910166e-01 | 0.719 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.591192e-01 | 0.445 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.611749e-01 | 0.583 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.458682e-01 | 0.461 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.458682e-01 | 0.461 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.458682e-01 | 0.461 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.458682e-01 | 0.461 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.458682e-01 | 0.461 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.458682e-01 | 0.461 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.280364e-01 | 0.369 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.280364e-01 | 0.369 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.363081e-01 | 0.627 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.699455e-01 | 0.569 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.053249e-01 | 0.392 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.053249e-01 | 0.392 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.940186e-01 | 0.532 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.940186e-01 | 0.532 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.705155e-01 | 0.431 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.705155e-01 | 0.431 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.434365e-01 | 0.464 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.669930e-01 | 0.574 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.140431e-01 | 0.383 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.363995e-01 | 0.360 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.363995e-01 | 0.360 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.644003e-01 | 0.333 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.644003e-01 | 0.333 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.030624e-01 | 0.298 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.030624e-01 | 0.298 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.030624e-01 | 0.298 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.700556e-01 | 0.244 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.700556e-01 | 0.244 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.700556e-01 | 0.244 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.700556e-01 | 0.244 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.700556e-01 | 0.244 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.706121e-01 | 0.431 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.852027e-01 | 0.414 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.852027e-01 | 0.414 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.852027e-01 | 0.414 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.014574e-01 | 0.396 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.444091e-01 | 0.352 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.997090e-01 | 0.301 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.997090e-01 | 0.301 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.997090e-01 | 0.301 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.997090e-01 | 0.301 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.271619e-01 | 0.369 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.867710e-01 | 0.413 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.004696e-01 | 0.397 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.969648e-01 | 0.304 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.969648e-01 | 0.304 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.969648e-01 | 0.304 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.456995e-01 | 0.263 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.456995e-01 | 0.263 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.854300e-01 | 0.414 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.854300e-01 | 0.414 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.499481e-01 | 0.347 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.946836e-01 | 0.306 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.688440e-01 | 0.329 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.688440e-01 | 0.329 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.688440e-01 | 0.329 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.909981e-01 | 0.309 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.514926e-01 | 0.345 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.894461e-01 | 0.310 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.261896e-01 | 0.279 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.261896e-01 | 0.279 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 5.261896e-01 | 0.279 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.163606e-01 | 0.287 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.163606e-01 | 0.287 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.545649e-01 | 0.256 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.665209e-01 | 0.247 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.857087e-01 | 0.232 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 6.264910e-01 | 0.203 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.264910e-01 | 0.203 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.264910e-01 | 0.203 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.264910e-01 | 0.203 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.264910e-01 | 0.203 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.264910e-01 | 0.203 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 6.264910e-01 | 0.203 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.264910e-01 | 0.203 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.264910e-01 | 0.203 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.264910e-01 | 0.203 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.264910e-01 | 0.203 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.264910e-01 | 0.203 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.208748e-01 | 0.283 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.208748e-01 | 0.283 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.253731e-01 | 0.280 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.622625e-01 | 0.250 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.691680e-01 | 0.245 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.820060e-01 | 0.235 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 5.977975e-01 | 0.223 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.948285e-01 | 0.226 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.948285e-01 | 0.226 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.050677e-01 | 0.218 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.149338e-01 | 0.211 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.230452e-01 | 0.205 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.230452e-01 | 0.205 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.230452e-01 | 0.205 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.230452e-01 | 0.205 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.253725e-01 | 0.204 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.275576e-01 | 0.202 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.275576e-01 | 0.202 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.275576e-01 | 0.202 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.486049e-01 | 0.188 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.351325e-01 | 0.197 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.338320e-01 | 0.198 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.537348e-01 | 0.185 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.557625e-01 | 0.183 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.557625e-01 | 0.183 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.577214e-01 | 0.182 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.577214e-01 | 0.182 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.755214e-01 | 0.170 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.755214e-01 | 0.170 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.755214e-01 | 0.170 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.755214e-01 | 0.170 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.755214e-01 | 0.170 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.755214e-01 | 0.170 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.755214e-01 | 0.170 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.755214e-01 | 0.170 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.755214e-01 | 0.170 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.755214e-01 | 0.170 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.755214e-01 | 0.170 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.755214e-01 | 0.170 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.875678e-01 | 0.312 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.803347e-01 | 0.318 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.715615e-01 | 0.766 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.014574e-01 | 0.396 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.448803e-01 | 0.264 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.760791e-01 | 0.240 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.155992e-01 | 0.666 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.567745e-01 | 0.805 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.644229e-01 | 0.784 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.024349e-01 | 0.694 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.024349e-01 | 0.694 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.306308e-01 | 0.275 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.405193e-01 | 0.193 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.255694e-01 | 0.647 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.775888e-01 | 0.557 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.132600e-01 | 0.946 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.318733e-01 | 0.199 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.159718e-01 | 0.210 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.971597e-01 | 0.527 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.688895e-01 | 0.772 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.264769e-01 | 0.645 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.098229e-01 | 0.293 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.665209e-01 | 0.247 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.340804e-01 | 0.873 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.672784e-01 | 0.330 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.275576e-01 | 0.202 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.335588e-01 | 0.874 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.213868e-01 | 0.207 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.715615e-01 | 0.766 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.909981e-01 | 0.309 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.665209e-01 | 0.247 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.688895e-01 | 0.772 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.287353e-01 | 0.641 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.943000e-01 | 0.404 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.880297e-01 | 0.312 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.128236e-01 | 0.290 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.159718e-01 | 0.210 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.275576e-01 | 0.202 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.497236e-01 | 0.260 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.432057e-01 | 0.614 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.509295e-01 | 0.346 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.581287e-01 | 0.182 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.836457e-01 | 0.416 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.395513e-01 | 0.621 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.499628e-01 | 0.602 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.971597e-01 | 0.527 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.936448e-01 | 0.713 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.053249e-01 | 0.392 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.627885e-01 | 0.580 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.548623e-01 | 0.594 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.460714e-01 | 0.263 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.072598e-01 | 0.390 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.369567e-01 | 0.270 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.968039e-01 | 0.706 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.940186e-01 | 0.532 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.094577e-01 | 0.509 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.708099e-01 | 0.244 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.854994e-01 | 0.732 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.854994e-01 | 0.732 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.193011e-01 | 0.659 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.378612e-01 | 0.359 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.583162e-01 | 0.253 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.509295e-01 | 0.346 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.132600e-01 | 0.946 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.395513e-01 | 0.621 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.449128e-01 | 0.839 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.104769e-01 | 0.387 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.739340e-01 | 0.427 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.030624e-01 | 0.298 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.337928e-01 | 0.273 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.857087e-01 | 0.232 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.061308e-01 | 0.217 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.755214e-01 | 0.170 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.053249e-01 | 0.392 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.061884e-01 | 0.391 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.293842e-01 | 0.888 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.591192e-01 | 0.445 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.138420e-01 | 0.212 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.395513e-01 | 0.621 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.482910e-01 | 0.605 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.420550e-01 | 0.616 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.583162e-01 | 0.253 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.341223e-01 | 0.362 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.341223e-01 | 0.362 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.061478e-01 | 0.686 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.654921e-01 | 0.332 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.654921e-01 | 0.332 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.575108e-01 | 0.803 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.622625e-01 | 0.250 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.669706e-01 | 0.435 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.070722e-01 | 0.684 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.585744e-01 | 0.587 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.030587e-01 | 0.692 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.905948e-01 | 0.720 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.102184e-01 | 0.508 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 2.491920e-01 | 0.603 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.885175e-01 | 0.725 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.579166e-01 | 0.339 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.030624e-01 | 0.298 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.030624e-01 | 0.298 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.328992e-01 | 0.478 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.800696e-01 | 0.420 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.946836e-01 | 0.306 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.622625e-01 | 0.250 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.275576e-01 | 0.202 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.428118e-01 | 0.192 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.557625e-01 | 0.183 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.577214e-01 | 0.182 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.577214e-01 | 0.182 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.454449e-01 | 0.837 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.180782e-01 | 0.209 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.132135e-01 | 0.212 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.867059e-01 | 0.232 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.545649e-01 | 0.256 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.885175e-01 | 0.725 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.548281e-01 | 0.450 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.269237e-01 | 0.203 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.707535e-01 | 0.431 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.681855e-01 | 0.330 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.232002e-01 | 0.205 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.839610e-01 | 0.735 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.908306e-01 | 0.408 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.642646e-01 | 0.439 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.412707e-01 | 0.355 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.946836e-01 | 0.306 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.720615e-01 | 0.173 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.442156e-01 | 0.352 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.341223e-01 | 0.362 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.921898e-01 | 0.716 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.559473e-01 | 0.592 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.203893e-01 | 0.376 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.350440e-01 | 0.361 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.896761e-01 | 0.538 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.699455e-01 | 0.569 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.458162e-01 | 0.836 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.287353e-01 | 0.641 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.540592e-01 | 0.451 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.395513e-01 | 0.621 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.102184e-01 | 0.508 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.491920e-01 | 0.603 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.610805e-01 | 0.442 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.243968e-01 | 0.649 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.739340e-01 | 0.427 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.579166e-01 | 0.339 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.802360e-01 | 0.744 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.314249e-01 | 0.365 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.875678e-01 | 0.312 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.857087e-01 | 0.232 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.264910e-01 | 0.203 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.554105e-01 | 0.255 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.722739e-01 | 0.242 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.338320e-01 | 0.198 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.493294e-01 | 0.188 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.128621e-01 | 0.384 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.585369e-01 | 0.181 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.584268e-01 | 0.800 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.885175e-01 | 0.725 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.803430e-01 | 0.318 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.424113e-01 | 0.465 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.725376e-01 | 0.763 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.548281e-01 | 0.450 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.493294e-01 | 0.188 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.491920e-01 | 0.603 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.344157e-01 | 0.872 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.432057e-01 | 0.614 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.338320e-01 | 0.198 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.577214e-01 | 0.182 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.476753e-01 | 0.831 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.720615e-01 | 0.173 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.271619e-01 | 0.369 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.575108e-01 | 0.803 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.914721e-01 | 0.718 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.903644e-01 | 0.720 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.325078e-01 | 0.478 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.051749e-01 | 0.688 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.199625e-01 | 0.921 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.546161e-01 | 0.594 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.644003e-01 | 0.333 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.264910e-01 | 0.203 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.755214e-01 | 0.170 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.299957e-01 | 0.276 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.389033e-01 | 0.622 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.434365e-01 | 0.464 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.510898e-01 | 0.455 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.542606e-01 | 0.812 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.575108e-01 | 0.803 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.140846e-01 | 0.503 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.696654e-01 | 0.432 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.430959e-01 | 0.844 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.181567e-01 | 0.661 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.971597e-01 | 0.527 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.116088e-01 | 0.506 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.460714e-01 | 0.263 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.337298e-01 | 0.363 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.345226e-01 | 0.871 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.822515e-01 | 0.317 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.030624e-01 | 0.298 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.577214e-01 | 0.182 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.898627e-01 | 0.722 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.898627e-01 | 0.722 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.690344e-01 | 0.570 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.297420e-01 | 0.887 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.431144e-01 | 0.614 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.224865e-01 | 0.912 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.775888e-01 | 0.557 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.116088e-01 | 0.506 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.581287e-01 | 0.182 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.770147e-01 | 0.557 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.642646e-01 | 0.439 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.622068e-01 | 0.335 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.743119e-01 | 0.427 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.705155e-01 | 0.431 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.275576e-01 | 0.202 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.557625e-01 | 0.183 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.302954e-01 | 0.481 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.329187e-01 | 0.364 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.472029e-01 | 0.189 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.952193e-01 | 0.403 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.330601e-01 | 0.633 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.141619e-01 | 0.669 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.855676e-01 | 0.544 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.186021e-01 | 0.378 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.014515e-01 | 0.521 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.014515e-01 | 0.521 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.117252e-01 | 0.674 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.452219e-01 | 0.610 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.070722e-01 | 0.684 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.442728e-01 | 0.463 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.442728e-01 | 0.463 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.442728e-01 | 0.463 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.442728e-01 | 0.463 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 1.132600e-01 | 0.946 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.030587e-01 | 0.692 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.631451e-01 | 0.787 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.631451e-01 | 0.787 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.395513e-01 | 0.621 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.102184e-01 | 0.508 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.303300e-01 | 0.366 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.303300e-01 | 0.366 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 4.303300e-01 | 0.366 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.303300e-01 | 0.366 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.303300e-01 | 0.366 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.303300e-01 | 0.366 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.255694e-01 | 0.647 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.109615e-01 | 0.507 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.109615e-01 | 0.507 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.104769e-01 | 0.387 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 5.050974e-01 | 0.297 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.578474e-01 | 0.802 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.424113e-01 | 0.465 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.579166e-01 | 0.339 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.936193e-01 | 0.532 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.699455e-01 | 0.569 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.198513e-01 | 0.658 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.029846e-01 | 0.519 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.390380e-01 | 0.470 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.700556e-01 | 0.244 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.700556e-01 | 0.244 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.067611e-01 | 0.513 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.172923e-01 | 0.380 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.456995e-01 | 0.263 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.927246e-01 | 0.307 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.261896e-01 | 0.279 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 5.545649e-01 | 0.256 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.857087e-01 | 0.232 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.264910e-01 | 0.203 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.264910e-01 | 0.203 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.264910e-01 | 0.203 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.264910e-01 | 0.203 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.230431e-01 | 0.281 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.820060e-01 | 0.235 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.755214e-01 | 0.170 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.755214e-01 | 0.170 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.755214e-01 | 0.170 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.011562e-01 | 0.300 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.110442e-01 | 0.507 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.046428e-01 | 0.689 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.885175e-01 | 0.725 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.843592e-01 | 0.315 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.582046e-01 | 0.253 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.971597e-01 | 0.527 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.505213e-01 | 0.346 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.044066e-01 | 0.517 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.644229e-01 | 0.784 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.537348e-01 | 0.185 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.007428e-01 | 0.697 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.405193e-01 | 0.193 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.622625e-01 | 0.250 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.228940e-01 | 0.282 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.510898e-01 | 0.455 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.019595e-01 | 0.396 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.329094e-01 | 0.876 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.903644e-01 | 0.720 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.240521e-01 | 0.373 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.456995e-01 | 0.263 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.456995e-01 | 0.263 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.665209e-01 | 0.247 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.264910e-01 | 0.203 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.448803e-01 | 0.264 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.500416e-01 | 0.187 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.717199e-01 | 0.765 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.480654e-01 | 0.349 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.102184e-01 | 0.508 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.610805e-01 | 0.442 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.272117e-01 | 0.644 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.104769e-01 | 0.387 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.739340e-01 | 0.427 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.280364e-01 | 0.369 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.700556e-01 | 0.244 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.390233e-01 | 0.470 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.669939e-01 | 0.331 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.203655e-01 | 0.284 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.755214e-01 | 0.170 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.755214e-01 | 0.170 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.655540e-01 | 0.781 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.493967e-01 | 0.603 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.280364e-01 | 0.369 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.338320e-01 | 0.198 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.661706e-01 | 0.176 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.885175e-01 | 0.725 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.553308e-01 | 0.809 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.842699e-01 | 0.546 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.568831e-01 | 0.183 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.732009e-01 | 0.325 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.442728e-01 | 0.463 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.303300e-01 | 0.366 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.303300e-01 | 0.366 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.303300e-01 | 0.366 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.149835e-01 | 0.502 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.050974e-01 | 0.297 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.050974e-01 | 0.297 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.044565e-01 | 0.516 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.424113e-01 | 0.465 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.280364e-01 | 0.369 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.510898e-01 | 0.455 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.140431e-01 | 0.383 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.700556e-01 | 0.244 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.456995e-01 | 0.263 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.456995e-01 | 0.263 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.456995e-01 | 0.263 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.927246e-01 | 0.307 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.460714e-01 | 0.263 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.857087e-01 | 0.232 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 6.264910e-01 | 0.203 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.230452e-01 | 0.205 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.230452e-01 | 0.205 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.428118e-01 | 0.192 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.755214e-01 | 0.170 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.412707e-01 | 0.355 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.717585e-01 | 0.173 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.689753e-01 | 0.772 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.610805e-01 | 0.442 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.050974e-01 | 0.297 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.855676e-01 | 0.544 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.857087e-01 | 0.232 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.084455e-01 | 0.216 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.147532e-01 | 0.940 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.997090e-01 | 0.301 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.457288e-01 | 0.836 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.557625e-01 | 0.183 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.472029e-01 | 0.189 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.104769e-01 | 0.387 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.050974e-01 | 0.297 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.125405e-01 | 0.505 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.940186e-01 | 0.532 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.700556e-01 | 0.244 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.700556e-01 | 0.244 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.700556e-01 | 0.244 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.681855e-01 | 0.330 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.264910e-01 | 0.203 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.820060e-01 | 0.235 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.755214e-01 | 0.170 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.755214e-01 | 0.170 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.094577e-01 | 0.509 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.128236e-01 | 0.290 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.338320e-01 | 0.198 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.969648e-01 | 0.304 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.275576e-01 | 0.202 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.557625e-01 | 0.183 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.030624e-01 | 0.298 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.456995e-01 | 0.263 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 6.264910e-01 | 0.203 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.621214e-01 | 0.179 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.755214e-01 | 0.170 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.299066e-01 | 0.886 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.275576e-01 | 0.202 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.871756e-01 | 0.728 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.142358e-01 | 0.289 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.280364e-01 | 0.369 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 4.644003e-01 | 0.333 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.505213e-01 | 0.346 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.261896e-01 | 0.279 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.918066e-01 | 0.228 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.579166e-01 | 0.339 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 5.700556e-01 | 0.244 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.755214e-01 | 0.170 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.577214e-01 | 0.182 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.336148e-01 | 0.198 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.456995e-01 | 0.263 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.768098e-01 | 0.170 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.774925e-01 | 0.169 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.782515e-01 | 0.169 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.808568e-01 | 0.167 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.813119e-01 | 0.167 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.813119e-01 | 0.167 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.823965e-01 | 0.166 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.823965e-01 | 0.166 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.823965e-01 | 0.166 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.823965e-01 | 0.166 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.828625e-01 | 0.166 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.856912e-01 | 0.164 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.856912e-01 | 0.164 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.856912e-01 | 0.164 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.868385e-01 | 0.163 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.891874e-01 | 0.162 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.891874e-01 | 0.162 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.897921e-01 | 0.161 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.897921e-01 | 0.161 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.897921e-01 | 0.161 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.897921e-01 | 0.161 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.917357e-01 | 0.160 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.917357e-01 | 0.160 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.919462e-01 | 0.160 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.936451e-01 | 0.159 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.986030e-01 | 0.156 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.027281e-01 | 0.153 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.027281e-01 | 0.153 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.033698e-01 | 0.153 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.033698e-01 | 0.153 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.038676e-01 | 0.153 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.038676e-01 | 0.153 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.061192e-01 | 0.151 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.074632e-01 | 0.150 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.074632e-01 | 0.150 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.094917e-01 | 0.149 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.094917e-01 | 0.149 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.181181e-01 | 0.144 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.181181e-01 | 0.144 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.181181e-01 | 0.144 | 0 | 0 |
| Defective CYP11A1 causes AICSR | R-HSA-5579026 | 7.181181e-01 | 0.144 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 7.181181e-01 | 0.144 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.181181e-01 | 0.144 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.181181e-01 | 0.144 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.181181e-01 | 0.144 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.181181e-01 | 0.144 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.181181e-01 | 0.144 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.181181e-01 | 0.144 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.193440e-01 | 0.143 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.193440e-01 | 0.143 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.193440e-01 | 0.143 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.193440e-01 | 0.143 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.213189e-01 | 0.142 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.217108e-01 | 0.142 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.217108e-01 | 0.142 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.239126e-01 | 0.140 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.239126e-01 | 0.140 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.239853e-01 | 0.140 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.243006e-01 | 0.140 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.243006e-01 | 0.140 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.243006e-01 | 0.140 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.243006e-01 | 0.140 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.256454e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.309819e-01 | 0.136 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.373701e-01 | 0.132 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.373701e-01 | 0.132 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.378020e-01 | 0.132 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.378020e-01 | 0.132 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.378020e-01 | 0.132 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.380410e-01 | 0.132 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.380410e-01 | 0.132 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.383676e-01 | 0.132 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.385409e-01 | 0.132 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.398097e-01 | 0.131 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.398097e-01 | 0.131 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.404371e-01 | 0.131 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.410259e-01 | 0.130 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.417621e-01 | 0.130 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.441117e-01 | 0.128 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.441117e-01 | 0.128 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.464854e-01 | 0.127 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.464854e-01 | 0.127 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.464854e-01 | 0.127 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.464854e-01 | 0.127 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.464854e-01 | 0.127 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.464854e-01 | 0.127 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.464854e-01 | 0.127 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.527660e-01 | 0.123 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.528780e-01 | 0.123 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.529853e-01 | 0.123 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.529853e-01 | 0.123 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.529853e-01 | 0.123 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.529853e-01 | 0.123 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.529853e-01 | 0.123 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.529853e-01 | 0.123 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.540342e-01 | 0.123 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.540342e-01 | 0.123 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.544200e-01 | 0.122 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.551249e-01 | 0.122 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.551249e-01 | 0.122 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.551249e-01 | 0.122 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.551249e-01 | 0.122 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.551249e-01 | 0.122 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.551249e-01 | 0.122 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.551249e-01 | 0.122 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.551249e-01 | 0.122 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.551249e-01 | 0.122 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.551249e-01 | 0.122 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.551249e-01 | 0.122 | 0 | 0 |
| Electron transport from NADPH to Ferredoxin | R-HSA-2395516 | 7.551249e-01 | 0.122 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.551249e-01 | 0.122 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.551249e-01 | 0.122 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 7.551249e-01 | 0.122 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.551249e-01 | 0.122 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.551249e-01 | 0.122 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.551249e-01 | 0.122 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.551249e-01 | 0.122 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.551249e-01 | 0.122 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.570292e-01 | 0.121 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.595328e-01 | 0.119 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.595328e-01 | 0.119 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.595328e-01 | 0.119 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.598246e-01 | 0.119 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.622971e-01 | 0.118 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.628183e-01 | 0.118 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.628183e-01 | 0.118 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.650627e-01 | 0.116 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.650627e-01 | 0.116 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.660973e-01 | 0.116 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.661692e-01 | 0.116 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.661692e-01 | 0.116 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.666440e-01 | 0.115 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.690913e-01 | 0.114 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.693023e-01 | 0.114 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.713399e-01 | 0.113 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.713399e-01 | 0.113 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.713399e-01 | 0.113 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.713399e-01 | 0.113 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.713399e-01 | 0.113 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.713399e-01 | 0.113 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.713399e-01 | 0.113 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 7.713399e-01 | 0.113 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.713399e-01 | 0.113 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.735164e-01 | 0.112 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.735164e-01 | 0.112 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.804420e-01 | 0.108 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.808348e-01 | 0.107 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.872752e-01 | 0.104 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.872752e-01 | 0.104 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.872752e-01 | 0.104 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.872752e-01 | 0.104 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.872752e-01 | 0.104 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.872752e-01 | 0.104 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.872752e-01 | 0.104 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.872752e-01 | 0.104 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.872752e-01 | 0.104 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.872752e-01 | 0.104 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.872752e-01 | 0.104 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.872752e-01 | 0.104 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.872752e-01 | 0.104 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.872752e-01 | 0.104 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.872752e-01 | 0.104 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.872752e-01 | 0.104 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.872752e-01 | 0.104 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.888726e-01 | 0.103 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.897921e-01 | 0.102 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.898017e-01 | 0.102 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.909989e-01 | 0.102 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.920171e-01 | 0.101 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.926264e-01 | 0.101 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.926264e-01 | 0.101 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.926264e-01 | 0.101 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 7.940401e-01 | 0.100 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.940401e-01 | 0.100 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.940401e-01 | 0.100 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.940401e-01 | 0.100 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.940401e-01 | 0.100 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.940401e-01 | 0.100 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.940401e-01 | 0.100 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.940401e-01 | 0.100 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.940401e-01 | 0.100 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.940401e-01 | 0.100 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.970100e-01 | 0.099 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.992497e-01 | 0.097 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.033895e-01 | 0.095 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.035691e-01 | 0.095 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.037791e-01 | 0.095 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.095039e-01 | 0.092 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.101155e-01 | 0.091 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.103725e-01 | 0.091 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.103725e-01 | 0.091 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.103725e-01 | 0.091 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.108439e-01 | 0.091 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.112243e-01 | 0.091 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.125538e-01 | 0.090 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.125538e-01 | 0.090 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.125538e-01 | 0.090 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.125538e-01 | 0.090 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.139679e-01 | 0.089 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.147230e-01 | 0.089 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.147230e-01 | 0.089 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.147230e-01 | 0.089 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.147230e-01 | 0.089 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.147230e-01 | 0.089 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.152060e-01 | 0.089 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.152060e-01 | 0.089 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.152060e-01 | 0.089 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.152060e-01 | 0.089 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.152060e-01 | 0.089 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 8.152060e-01 | 0.089 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.152060e-01 | 0.089 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.152060e-01 | 0.089 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.152060e-01 | 0.089 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.152060e-01 | 0.089 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 8.152060e-01 | 0.089 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.173652e-01 | 0.088 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.173652e-01 | 0.088 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.194428e-01 | 0.086 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.215642e-01 | 0.085 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.217358e-01 | 0.085 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.217358e-01 | 0.085 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.220212e-01 | 0.085 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.258728e-01 | 0.083 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.268167e-01 | 0.083 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.268167e-01 | 0.083 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.271087e-01 | 0.082 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.271087e-01 | 0.082 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.331803e-01 | 0.079 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.331803e-01 | 0.079 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.335270e-01 | 0.079 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.335270e-01 | 0.079 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.335270e-01 | 0.079 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.365519e-01 | 0.078 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.365519e-01 | 0.078 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.365519e-01 | 0.078 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.371575e-01 | 0.077 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.394709e-01 | 0.076 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.394709e-01 | 0.076 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.394709e-01 | 0.076 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.394709e-01 | 0.076 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.394709e-01 | 0.076 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.394709e-01 | 0.076 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.394709e-01 | 0.076 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.394709e-01 | 0.076 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.394709e-01 | 0.076 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.394709e-01 | 0.076 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.394709e-01 | 0.076 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.396152e-01 | 0.076 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.404972e-01 | 0.075 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.404972e-01 | 0.075 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.404972e-01 | 0.075 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.404972e-01 | 0.075 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.404972e-01 | 0.075 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.404972e-01 | 0.075 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.404972e-01 | 0.075 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.407124e-01 | 0.075 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.407124e-01 | 0.075 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.420235e-01 | 0.075 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.420235e-01 | 0.075 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.420235e-01 | 0.075 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.420235e-01 | 0.075 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.449916e-01 | 0.073 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.462828e-01 | 0.072 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.462828e-01 | 0.072 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.505889e-01 | 0.070 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.505889e-01 | 0.070 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.518895e-01 | 0.070 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.542142e-01 | 0.068 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.560592e-01 | 0.067 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.568226e-01 | 0.067 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.570284e-01 | 0.067 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.586255e-01 | 0.066 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.597163e-01 | 0.066 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.605508e-01 | 0.065 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.605508e-01 | 0.065 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.605508e-01 | 0.065 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.605508e-01 | 0.065 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.605508e-01 | 0.065 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.605508e-01 | 0.065 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.605508e-01 | 0.065 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.605508e-01 | 0.065 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.605508e-01 | 0.065 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.605508e-01 | 0.065 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.605508e-01 | 0.065 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.605508e-01 | 0.065 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.611953e-01 | 0.065 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.650328e-01 | 0.063 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.650328e-01 | 0.063 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.652276e-01 | 0.063 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.660418e-01 | 0.062 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.660418e-01 | 0.062 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.660418e-01 | 0.062 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.660418e-01 | 0.062 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.660418e-01 | 0.062 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.689910e-01 | 0.061 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.689910e-01 | 0.061 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.689910e-01 | 0.061 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.689910e-01 | 0.061 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.696470e-01 | 0.061 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.737929e-01 | 0.059 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.761174e-01 | 0.057 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.766733e-01 | 0.057 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.775985e-01 | 0.057 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.788637e-01 | 0.056 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.788637e-01 | 0.056 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.788637e-01 | 0.056 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.788637e-01 | 0.056 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.788637e-01 | 0.056 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.788637e-01 | 0.056 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.788637e-01 | 0.056 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.788637e-01 | 0.056 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.788637e-01 | 0.056 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.788637e-01 | 0.056 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.800139e-01 | 0.056 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.800139e-01 | 0.056 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.800139e-01 | 0.056 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.800139e-01 | 0.056 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.800139e-01 | 0.056 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.807381e-01 | 0.055 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.808854e-01 | 0.055 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.808854e-01 | 0.055 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.808854e-01 | 0.055 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.808854e-01 | 0.055 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.808854e-01 | 0.055 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.808854e-01 | 0.055 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.864316e-01 | 0.052 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.864316e-01 | 0.052 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.864316e-01 | 0.052 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.878597e-01 | 0.052 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.886745e-01 | 0.051 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.913213e-01 | 0.050 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.918083e-01 | 0.050 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.920150e-01 | 0.050 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.926277e-01 | 0.049 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.926277e-01 | 0.049 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.944034e-01 | 0.048 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.947726e-01 | 0.048 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.947726e-01 | 0.048 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.947726e-01 | 0.048 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.947726e-01 | 0.048 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.947726e-01 | 0.048 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.947726e-01 | 0.048 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.947726e-01 | 0.048 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.947726e-01 | 0.048 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.947726e-01 | 0.048 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.947726e-01 | 0.048 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.947726e-01 | 0.048 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.947726e-01 | 0.048 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.947726e-01 | 0.048 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.947726e-01 | 0.048 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.947726e-01 | 0.048 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.947726e-01 | 0.048 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.947726e-01 | 0.048 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.947726e-01 | 0.048 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.949789e-01 | 0.048 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.958977e-01 | 0.048 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.958977e-01 | 0.048 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.958977e-01 | 0.048 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.958977e-01 | 0.048 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.958977e-01 | 0.048 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.958977e-01 | 0.048 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.971185e-01 | 0.047 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.975694e-01 | 0.047 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.975694e-01 | 0.047 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.975694e-01 | 0.047 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.009343e-01 | 0.045 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.012281e-01 | 0.045 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.012281e-01 | 0.045 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.018238e-01 | 0.045 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.039989e-01 | 0.044 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.039989e-01 | 0.044 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.039989e-01 | 0.044 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.039989e-01 | 0.044 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.039989e-01 | 0.044 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.046625e-01 | 0.044 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.046625e-01 | 0.044 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.067462e-01 | 0.043 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.081985e-01 | 0.042 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.082362e-01 | 0.042 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.085929e-01 | 0.042 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.085929e-01 | 0.042 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.085929e-01 | 0.042 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.085929e-01 | 0.042 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.085929e-01 | 0.042 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.085929e-01 | 0.042 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.085929e-01 | 0.042 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.085929e-01 | 0.042 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.085929e-01 | 0.042 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.085929e-01 | 0.042 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.085929e-01 | 0.042 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.085929e-01 | 0.042 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.085929e-01 | 0.042 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.085929e-01 | 0.042 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.085929e-01 | 0.042 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.093594e-01 | 0.041 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.094649e-01 | 0.041 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.105989e-01 | 0.041 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.109942e-01 | 0.040 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.109942e-01 | 0.040 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.117449e-01 | 0.040 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.124492e-01 | 0.040 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.127671e-01 | 0.040 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.127671e-01 | 0.040 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.127671e-01 | 0.040 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.142362e-01 | 0.039 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.142362e-01 | 0.039 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.142362e-01 | 0.039 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.142362e-01 | 0.039 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.142362e-01 | 0.039 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.149972e-01 | 0.039 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.166297e-01 | 0.038 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.166297e-01 | 0.038 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.166297e-01 | 0.038 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.168210e-01 | 0.038 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.193235e-01 | 0.037 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.193794e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.193794e-01 | 0.037 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.193794e-01 | 0.037 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.193794e-01 | 0.037 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.196601e-01 | 0.036 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.205989e-01 | 0.036 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.205989e-01 | 0.036 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 9.205989e-01 | 0.036 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.205989e-01 | 0.036 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.205989e-01 | 0.036 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.205989e-01 | 0.036 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.205989e-01 | 0.036 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.205989e-01 | 0.036 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.205989e-01 | 0.036 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.205989e-01 | 0.036 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.205989e-01 | 0.036 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.205989e-01 | 0.036 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.205989e-01 | 0.036 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.205989e-01 | 0.036 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.206692e-01 | 0.036 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.209150e-01 | 0.036 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.213531e-01 | 0.036 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.213531e-01 | 0.036 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.213531e-01 | 0.036 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.217200e-01 | 0.035 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.234412e-01 | 0.035 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.234412e-01 | 0.035 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.234412e-01 | 0.035 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.234412e-01 | 0.035 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.234412e-01 | 0.035 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.270368e-01 | 0.033 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.270368e-01 | 0.033 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.270368e-01 | 0.033 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.270368e-01 | 0.033 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.270368e-01 | 0.033 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.270368e-01 | 0.033 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.271547e-01 | 0.033 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.272887e-01 | 0.033 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.278187e-01 | 0.033 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.291834e-01 | 0.032 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.294736e-01 | 0.032 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.310285e-01 | 0.031 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.310285e-01 | 0.031 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.310285e-01 | 0.031 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.310285e-01 | 0.031 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.310285e-01 | 0.031 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.310285e-01 | 0.031 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.310285e-01 | 0.031 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.310285e-01 | 0.031 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.310285e-01 | 0.031 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.310285e-01 | 0.031 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.310285e-01 | 0.031 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.310285e-01 | 0.031 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.310285e-01 | 0.031 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.310285e-01 | 0.031 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.317085e-01 | 0.031 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.317085e-01 | 0.031 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.317085e-01 | 0.031 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.317085e-01 | 0.031 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.322419e-01 | 0.030 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.322419e-01 | 0.030 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.328260e-01 | 0.030 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.335144e-01 | 0.030 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.335144e-01 | 0.030 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.335144e-01 | 0.030 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.340208e-01 | 0.030 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.340208e-01 | 0.030 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.340208e-01 | 0.030 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.347331e-01 | 0.029 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.361992e-01 | 0.029 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.379866e-01 | 0.028 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.391255e-01 | 0.027 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.391255e-01 | 0.027 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.391255e-01 | 0.027 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.391255e-01 | 0.027 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.391255e-01 | 0.027 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.391255e-01 | 0.027 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.391255e-01 | 0.027 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.393666e-01 | 0.027 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.393666e-01 | 0.027 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.395420e-01 | 0.027 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.400886e-01 | 0.027 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.400886e-01 | 0.027 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.400886e-01 | 0.027 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.400886e-01 | 0.027 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.400886e-01 | 0.027 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.400886e-01 | 0.027 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.400886e-01 | 0.027 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.400886e-01 | 0.027 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.400886e-01 | 0.027 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.400886e-01 | 0.027 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.400886e-01 | 0.027 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.403833e-01 | 0.027 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.403833e-01 | 0.027 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.403833e-01 | 0.027 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.405225e-01 | 0.027 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.410548e-01 | 0.026 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.414723e-01 | 0.026 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.434518e-01 | 0.025 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.434518e-01 | 0.025 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.447458e-01 | 0.025 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.456159e-01 | 0.024 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.457729e-01 | 0.024 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.457729e-01 | 0.024 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.457729e-01 | 0.024 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.461731e-01 | 0.024 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.479591e-01 | 0.023 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.479591e-01 | 0.023 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.479591e-01 | 0.023 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.479591e-01 | 0.023 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.479591e-01 | 0.023 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.479591e-01 | 0.023 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.479591e-01 | 0.023 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.486382e-01 | 0.023 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.514361e-01 | 0.022 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.517157e-01 | 0.021 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.517248e-01 | 0.021 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.532247e-01 | 0.021 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.542161e-01 | 0.020 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.547960e-01 | 0.020 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.547960e-01 | 0.020 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.547960e-01 | 0.020 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.547960e-01 | 0.020 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.547960e-01 | 0.020 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.547960e-01 | 0.020 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.547960e-01 | 0.020 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.550235e-01 | 0.020 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.550235e-01 | 0.020 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.553567e-01 | 0.020 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.569732e-01 | 0.019 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.570493e-01 | 0.019 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.580636e-01 | 0.019 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.582894e-01 | 0.019 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.589919e-01 | 0.018 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.605513e-01 | 0.017 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.605513e-01 | 0.017 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.607351e-01 | 0.017 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.607351e-01 | 0.017 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.607351e-01 | 0.017 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.607351e-01 | 0.017 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.607351e-01 | 0.017 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.607351e-01 | 0.017 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.607351e-01 | 0.017 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.607351e-01 | 0.017 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.616372e-01 | 0.017 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.618084e-01 | 0.017 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.618084e-01 | 0.017 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.618084e-01 | 0.017 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.621597e-01 | 0.017 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.628458e-01 | 0.016 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.635712e-01 | 0.016 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.644812e-01 | 0.016 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.644812e-01 | 0.016 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.644812e-01 | 0.016 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.649990e-01 | 0.015 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.656462e-01 | 0.015 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.656916e-01 | 0.015 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.658942e-01 | 0.015 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.658942e-01 | 0.015 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.658942e-01 | 0.015 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.658942e-01 | 0.015 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.658942e-01 | 0.015 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.658942e-01 | 0.015 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.658942e-01 | 0.015 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.658942e-01 | 0.015 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.658942e-01 | 0.015 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.659872e-01 | 0.015 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.660236e-01 | 0.015 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.660587e-01 | 0.015 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.660587e-01 | 0.015 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.660587e-01 | 0.015 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.660587e-01 | 0.015 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.661476e-01 | 0.015 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.674006e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.680398e-01 | 0.014 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.680398e-01 | 0.014 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.688236e-01 | 0.014 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.697148e-01 | 0.013 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.698518e-01 | 0.013 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.703756e-01 | 0.013 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.703756e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.703756e-01 | 0.013 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.703756e-01 | 0.013 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.712596e-01 | 0.013 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.712596e-01 | 0.013 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.712596e-01 | 0.013 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.712596e-01 | 0.013 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.732344e-01 | 0.012 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.732344e-01 | 0.012 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.741704e-01 | 0.011 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.742685e-01 | 0.011 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.742685e-01 | 0.011 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.742685e-01 | 0.011 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.742685e-01 | 0.011 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.742685e-01 | 0.011 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.742685e-01 | 0.011 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.742685e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.742685e-01 | 0.011 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.742685e-01 | 0.011 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.742685e-01 | 0.011 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.754465e-01 | 0.011 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.770681e-01 | 0.010 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.776500e-01 | 0.010 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.776500e-01 | 0.010 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.776500e-01 | 0.010 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.776500e-01 | 0.010 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.776500e-01 | 0.010 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.776500e-01 | 0.010 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.776500e-01 | 0.010 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.780484e-01 | 0.010 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.787514e-01 | 0.009 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.789335e-01 | 0.009 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.789335e-01 | 0.009 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.789335e-01 | 0.009 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.789335e-01 | 0.009 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.791729e-01 | 0.009 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.791729e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.793287e-01 | 0.009 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.805872e-01 | 0.009 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.805872e-01 | 0.009 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.805872e-01 | 0.009 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.805872e-01 | 0.009 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.805872e-01 | 0.009 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.809831e-01 | 0.008 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.813135e-01 | 0.008 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.824094e-01 | 0.008 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.826110e-01 | 0.008 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.828027e-01 | 0.008 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.831386e-01 | 0.007 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.831386e-01 | 0.007 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.831386e-01 | 0.007 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.831386e-01 | 0.007 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.831386e-01 | 0.007 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.831386e-01 | 0.007 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.831386e-01 | 0.007 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.831386e-01 | 0.007 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.831761e-01 | 0.007 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.832429e-01 | 0.007 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.834483e-01 | 0.007 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.834483e-01 | 0.007 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.841808e-01 | 0.007 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.844565e-01 | 0.007 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.847746e-01 | 0.007 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.849806e-01 | 0.007 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.853378e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.853378e-01 | 0.006 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.853378e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.853378e-01 | 0.006 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.853378e-01 | 0.006 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.853378e-01 | 0.006 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.853549e-01 | 0.006 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.853549e-01 | 0.006 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.853549e-01 | 0.006 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.853549e-01 | 0.006 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.853549e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.853549e-01 | 0.006 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.853549e-01 | 0.006 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.855124e-01 | 0.006 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.859586e-01 | 0.006 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.863799e-01 | 0.006 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.865420e-01 | 0.006 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.870167e-01 | 0.006 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.870167e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.872799e-01 | 0.006 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.872799e-01 | 0.006 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.872799e-01 | 0.006 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.876038e-01 | 0.005 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.878546e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.885077e-01 | 0.005 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.886953e-01 | 0.005 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.887863e-01 | 0.005 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.889520e-01 | 0.005 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.889520e-01 | 0.005 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.892167e-01 | 0.005 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.903532e-01 | 0.004 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.904043e-01 | 0.004 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.904043e-01 | 0.004 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.904043e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.904043e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.904043e-01 | 0.004 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.904265e-01 | 0.004 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.910054e-01 | 0.004 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.912028e-01 | 0.004 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.916659e-01 | 0.004 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.916659e-01 | 0.004 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.916659e-01 | 0.004 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.916659e-01 | 0.004 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.922894e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.923779e-01 | 0.003 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.927616e-01 | 0.003 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.927616e-01 | 0.003 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.930030e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.932592e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.936780e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.936780e-01 | 0.003 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.937876e-01 | 0.003 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.938473e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.938799e-01 | 0.003 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.939472e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.942886e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.945071e-01 | 0.002 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.945277e-01 | 0.002 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.945400e-01 | 0.002 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.945400e-01 | 0.002 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.946493e-01 | 0.002 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.948118e-01 | 0.002 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.950493e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.950493e-01 | 0.002 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.954372e-01 | 0.002 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.954783e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.954783e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.955500e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.956271e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.956271e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.957210e-01 | 0.002 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.957210e-01 | 0.002 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.957210e-01 | 0.002 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.958815e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.961004e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.961004e-01 | 0.002 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.962232e-01 | 0.002 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.962232e-01 | 0.002 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.966674e-01 | 0.001 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.966674e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.968088e-01 | 0.001 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.968936e-01 | 0.001 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.968936e-01 | 0.001 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.968936e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.968936e-01 | 0.001 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.968936e-01 | 0.001 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.968936e-01 | 0.001 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.968936e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.969286e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.971064e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.973022e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.973022e-01 | 0.001 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.973022e-01 | 0.001 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.973185e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.974071e-01 | 0.001 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.974548e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.975126e-01 | 0.001 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.975424e-01 | 0.001 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.979652e-01 | 0.001 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.979652e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.979652e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.979652e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.980528e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.981293e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.981348e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.982238e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.982269e-01 | 0.001 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.982329e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.982329e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.982329e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.982676e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.982676e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.984654e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.984654e-01 | 0.001 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.984654e-01 | 0.001 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.984654e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.986213e-01 | 0.001 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.986374e-01 | 0.001 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.986523e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.986673e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.986673e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.986673e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.987857e-01 | 0.001 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.987971e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.987971e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.988166e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.988426e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.988966e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.989177e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.990384e-01 | 0.000 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.990430e-01 | 0.000 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.991272e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.991272e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.992304e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.992416e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.992420e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.992420e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.993122e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.993267e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.993584e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.994057e-01 | 0.000 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.994284e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.994960e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.995690e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.995705e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.995719e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.996257e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.996515e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.996750e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997034e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.997246e-01 | 0.000 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.997443e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.997549e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.997549e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.997719e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998232e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998232e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998636e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998790e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998949e-01 | 0.000 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.999280e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999283e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999289e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.999289e-01 | 0.000 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.999311e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999311e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.999312e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999312e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999342e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999376e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999403e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.999403e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999427e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.999482e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999520e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999550e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999550e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999661e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999691e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999698e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999741e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999744e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999778e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999871e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999874e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999883e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999903e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999924e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999946e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999955e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999970e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999988e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999988e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999989e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999989e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999989e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999991e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999993e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999995e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999996e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999996e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999997e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.997602e-15 | 14.523 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.121325e-14 | 13.950 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.893686e-14 | 13.103 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.409184e-13 | 12.618 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.242961e-13 | 12.489 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.452727e-12 | 11.838 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.016276e-12 | 11.695 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.840284e-12 | 11.547 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.748002e-12 | 11.426 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.079626e-12 | 11.389 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.024902e-11 | 10.989 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.044731e-11 | 10.981 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.044731e-11 | 10.981 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.236122e-11 | 10.490 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.246159e-10 | 9.904 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.286949e-10 | 9.890 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.574922e-10 | 9.803 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.903233e-10 | 9.721 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.323203e-10 | 9.634 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.634063e-10 | 9.579 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.233287e-10 | 9.373 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.048283e-10 | 9.297 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.014779e-10 | 9.300 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.485833e-10 | 9.261 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.201053e-10 | 9.208 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.075874e-09 | 8.968 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.084776e-09 | 8.965 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.084776e-09 | 8.965 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.428302e-09 | 8.845 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.494515e-09 | 8.825 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.568986e-09 | 8.804 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.772112e-09 | 8.752 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.002116e-09 | 8.699 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.389800e-09 | 8.622 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.522397e-09 | 8.598 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.599518e-09 | 8.444 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.523782e-09 | 8.453 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.357507e-09 | 8.197 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.988265e-09 | 8.156 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.026166e-08 | 7.989 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.026166e-08 | 7.989 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.207118e-08 | 7.918 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.661653e-08 | 7.779 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.143596e-08 | 7.669 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.535185e-08 | 7.596 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.370477e-08 | 7.472 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.207728e-08 | 7.283 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.875466e-08 | 7.231 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.323316e-08 | 7.199 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.293149e-08 | 7.137 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.418912e-08 | 7.130 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.093142e-08 | 7.041 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.996692e-08 | 7.046 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.629740e-08 | 7.016 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.111567e-07 | 6.954 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.163094e-07 | 6.934 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.735161e-07 | 6.761 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.084084e-07 | 6.681 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.084391e-07 | 6.681 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.576530e-07 | 6.589 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.746004e-07 | 6.561 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.983435e-07 | 6.525 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.396506e-07 | 6.469 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.810174e-07 | 6.419 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.129960e-07 | 6.384 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.399358e-07 | 6.357 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.563951e-07 | 6.341 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.798842e-07 | 6.237 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.817826e-07 | 6.235 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.540364e-07 | 6.184 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.825720e-07 | 6.166 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.378933e-07 | 6.132 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.174089e-07 | 6.144 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.106012e-07 | 6.148 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.973609e-07 | 6.098 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.681225e-07 | 6.014 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.009734e-06 | 5.996 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110097e-06 | 5.955 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.177434e-06 | 5.929 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.359022e-06 | 5.867 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.365295e-06 | 5.865 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.466772e-06 | 5.834 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.517398e-06 | 5.819 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.576023e-06 | 5.802 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.595883e-06 | 5.797 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.706306e-06 | 5.768 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.932049e-06 | 5.714 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.970300e-06 | 5.705 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.160433e-06 | 5.665 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.349681e-06 | 5.629 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.585885e-06 | 5.587 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.719899e-06 | 5.565 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.752598e-06 | 5.560 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.235548e-06 | 5.490 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.394255e-06 | 5.469 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.406784e-06 | 5.468 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.876650e-06 | 5.312 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.876650e-06 | 5.312 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.887961e-06 | 5.311 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.313474e-06 | 5.275 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.556484e-06 | 5.183 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.131193e-06 | 5.147 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.170866e-06 | 5.144 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.710029e-06 | 5.113 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.313292e-06 | 5.080 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.814184e-06 | 5.055 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.299249e-06 | 5.032 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.411800e-06 | 5.026 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.016685e-05 | 4.993 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.072495e-05 | 4.970 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.077279e-05 | 4.968 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.402127e-05 | 4.853 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.462648e-05 | 4.835 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.526178e-05 | 4.816 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.542494e-05 | 4.812 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.705257e-05 | 4.768 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.753069e-05 | 4.756 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.788996e-05 | 4.747 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.959152e-05 | 4.708 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.209398e-05 | 4.656 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.352668e-05 | 4.628 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.157540e-05 | 4.501 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.813600e-05 | 4.419 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.116315e-05 | 4.385 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.233533e-05 | 4.373 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.302730e-05 | 4.366 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.584849e-05 | 4.339 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.084789e-05 | 4.294 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.187708e-05 | 4.143 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.395911e-05 | 4.131 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.990968e-05 | 4.097 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.001742e-05 | 4.097 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.160258e-05 | 4.088 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.160258e-05 | 4.088 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.160258e-05 | 4.088 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.160258e-05 | 4.088 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 8.524489e-05 | 4.069 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.640708e-05 | 4.063 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.524489e-05 | 4.069 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.921760e-05 | 4.050 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.291306e-05 | 4.032 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.291306e-05 | 4.032 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.085104e-04 | 3.965 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.085104e-04 | 3.965 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.127238e-04 | 3.948 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.136401e-04 | 3.944 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.155070e-04 | 3.937 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.292552e-04 | 3.889 | 0 | 0 |
| Translation | R-HSA-72766 | 1.295099e-04 | 3.888 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.486653e-04 | 3.828 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.401523e-04 | 3.853 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.401523e-04 | 3.853 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.416543e-04 | 3.849 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.489559e-04 | 3.827 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.520158e-04 | 3.818 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.681195e-04 | 3.774 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.891113e-04 | 3.723 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.990847e-04 | 3.701 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.078532e-04 | 3.682 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.124279e-04 | 3.673 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.142110e-04 | 3.669 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.142110e-04 | 3.669 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.168294e-04 | 3.664 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.168294e-04 | 3.664 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.206604e-04 | 3.656 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.429530e-04 | 3.614 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.526639e-04 | 3.597 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.520014e-04 | 3.599 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.561753e-04 | 3.591 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.899675e-04 | 3.538 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.318218e-04 | 3.479 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.976585e-04 | 3.400 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.579983e-04 | 3.339 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.041108e-04 | 3.297 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.115207e-04 | 3.291 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.357760e-04 | 3.271 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.357760e-04 | 3.271 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.439573e-04 | 3.264 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.467936e-04 | 3.262 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.552193e-04 | 3.256 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.924809e-04 | 3.227 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.182501e-04 | 3.209 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.649893e-04 | 3.177 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.054590e-04 | 3.152 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.928817e-04 | 3.049 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.219123e-04 | 3.085 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 9.446025e-04 | 3.025 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 9.474525e-04 | 3.023 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.029828e-03 | 2.987 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.031166e-03 | 2.987 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.031166e-03 | 2.987 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.042964e-03 | 2.982 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.081138e-03 | 2.966 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.082609e-03 | 2.966 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.126717e-03 | 2.948 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.195870e-03 | 2.922 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.287586e-03 | 2.890 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.287586e-03 | 2.890 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.309367e-03 | 2.883 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.364800e-03 | 2.865 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.375440e-03 | 2.862 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.400281e-03 | 2.854 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.508509e-03 | 2.821 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.675801e-03 | 2.776 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.645732e-03 | 2.784 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.586401e-03 | 2.800 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.586401e-03 | 2.800 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.505322e-03 | 2.822 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.508509e-03 | 2.821 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.686673e-03 | 2.773 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.735532e-03 | 2.761 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.741708e-03 | 2.759 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.019874e-03 | 2.695 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.157128e-03 | 2.666 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.164856e-03 | 2.665 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.294619e-03 | 2.639 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.320533e-03 | 2.634 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.320533e-03 | 2.634 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.423548e-03 | 2.616 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.425738e-03 | 2.615 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.710905e-03 | 2.567 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.737838e-03 | 2.563 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.737838e-03 | 2.563 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.737838e-03 | 2.563 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.737838e-03 | 2.563 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.771951e-03 | 2.557 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.771951e-03 | 2.557 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.786834e-03 | 2.555 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.803145e-03 | 2.552 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.803145e-03 | 2.552 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.828990e-03 | 2.548 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.849451e-03 | 2.545 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.955013e-03 | 2.529 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.199118e-03 | 2.495 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.319606e-03 | 2.479 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.195315e-03 | 2.495 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.064182e-03 | 2.514 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.064340e-03 | 2.514 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.556213e-03 | 2.449 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.608886e-03 | 2.443 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.840647e-03 | 2.416 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.901576e-03 | 2.409 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.913319e-03 | 2.407 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.916119e-03 | 2.407 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.980108e-03 | 2.400 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.991571e-03 | 2.399 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.310089e-03 | 2.366 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.362252e-03 | 2.360 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.408286e-03 | 2.356 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.585175e-03 | 2.339 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.596725e-03 | 2.338 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.608385e-03 | 2.336 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.608385e-03 | 2.336 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.774206e-03 | 2.321 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.939927e-03 | 2.306 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.409315e-03 | 2.267 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.409315e-03 | 2.267 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.433304e-03 | 2.265 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.433304e-03 | 2.265 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.467883e-03 | 2.262 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.913334e-03 | 2.228 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.178764e-03 | 2.209 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.655164e-03 | 2.177 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.655164e-03 | 2.177 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.457448e-03 | 2.190 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.457448e-03 | 2.190 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.341001e-03 | 2.134 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.341001e-03 | 2.134 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.341001e-03 | 2.134 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.341001e-03 | 2.134 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.341001e-03 | 2.134 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.341001e-03 | 2.134 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.341001e-03 | 2.134 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.341001e-03 | 2.134 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.610778e-03 | 2.119 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.169378e-03 | 2.145 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.385430e-03 | 2.195 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.341001e-03 | 2.134 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.457448e-03 | 2.190 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.732199e-03 | 2.112 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.038608e-03 | 2.095 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.051585e-03 | 2.094 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.051585e-03 | 2.094 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.051585e-03 | 2.094 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.378230e-03 | 2.077 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.378230e-03 | 2.077 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 8.378230e-03 | 2.077 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.903435e-03 | 2.050 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.903435e-03 | 2.050 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.148520e-03 | 2.039 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.148520e-03 | 2.039 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 9.172787e-03 | 2.037 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.172787e-03 | 2.037 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.240019e-03 | 2.034 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.624420e-03 | 2.017 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.690352e-03 | 2.014 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.780404e-03 | 2.010 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.046978e-02 | 1.980 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.046978e-02 | 1.980 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.046978e-02 | 1.980 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.062515e-02 | 1.974 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.066199e-02 | 1.972 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.123418e-02 | 1.949 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.155578e-02 | 1.937 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.195283e-02 | 1.923 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.195283e-02 | 1.923 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.242383e-02 | 1.906 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.242556e-02 | 1.906 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.253098e-02 | 1.902 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.255270e-02 | 1.901 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.255270e-02 | 1.901 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.258700e-02 | 1.900 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.258700e-02 | 1.900 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.263523e-02 | 1.898 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.302473e-02 | 1.885 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.306136e-02 | 1.884 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.608841e-02 | 1.793 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.591000e-02 | 1.798 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.591000e-02 | 1.798 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.591000e-02 | 1.798 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.591000e-02 | 1.798 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.491596e-02 | 1.826 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.488689e-02 | 1.827 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.444262e-02 | 1.840 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.669665e-02 | 1.777 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.426438e-02 | 1.846 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.426438e-02 | 1.846 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.491596e-02 | 1.826 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.574226e-02 | 1.803 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.433508e-02 | 1.844 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.669665e-02 | 1.777 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.488689e-02 | 1.827 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.492020e-02 | 1.826 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.407799e-02 | 1.851 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.669665e-02 | 1.777 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.677145e-02 | 1.775 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.677145e-02 | 1.775 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.677145e-02 | 1.775 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.677145e-02 | 1.775 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.677145e-02 | 1.775 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.677145e-02 | 1.775 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.742088e-02 | 1.759 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.742088e-02 | 1.759 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.742088e-02 | 1.759 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.751007e-02 | 1.757 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.782030e-02 | 1.749 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.796591e-02 | 1.746 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.846062e-02 | 1.734 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.880140e-02 | 1.726 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.897771e-02 | 1.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.897771e-02 | 1.722 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.897771e-02 | 1.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.897771e-02 | 1.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.897771e-02 | 1.722 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.897771e-02 | 1.722 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.951824e-02 | 1.710 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.961884e-02 | 1.707 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.025551e-02 | 1.693 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.039923e-02 | 1.690 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.042515e-02 | 1.690 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.045305e-02 | 1.689 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.077064e-02 | 1.683 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.095537e-02 | 1.679 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.163586e-02 | 1.665 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.168152e-02 | 1.664 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.175857e-02 | 1.662 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.175857e-02 | 1.662 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.178856e-02 | 1.662 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.178856e-02 | 1.662 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.178856e-02 | 1.662 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.178856e-02 | 1.662 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.196962e-02 | 1.658 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.265881e-02 | 1.645 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.306711e-02 | 1.637 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.340846e-02 | 1.631 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.340846e-02 | 1.631 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.340846e-02 | 1.631 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.340846e-02 | 1.631 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.372109e-02 | 1.625 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.445416e-02 | 1.612 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.445416e-02 | 1.612 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.506246e-02 | 1.601 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.506246e-02 | 1.601 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.506246e-02 | 1.601 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.506246e-02 | 1.601 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.506246e-02 | 1.601 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.553891e-02 | 1.593 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.577069e-02 | 1.589 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.577069e-02 | 1.589 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.605144e-02 | 1.584 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.609370e-02 | 1.583 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.645938e-02 | 1.577 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.689656e-02 | 1.570 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.709875e-02 | 1.567 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.769061e-02 | 1.558 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.769061e-02 | 1.558 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.853817e-02 | 1.545 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.853817e-02 | 1.545 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.940679e-02 | 1.532 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.845905e-02 | 1.415 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.451900e-02 | 1.462 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.296497e-02 | 1.482 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.121662e-02 | 1.506 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.587877e-02 | 1.445 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.820993e-02 | 1.418 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.845905e-02 | 1.415 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.964741e-02 | 1.528 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.940679e-02 | 1.532 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.569213e-02 | 1.447 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.969379e-02 | 1.527 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.073571e-02 | 1.512 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.940679e-02 | 1.532 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.845905e-02 | 1.415 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.596368e-02 | 1.444 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.939688e-02 | 1.532 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.820107e-02 | 1.418 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.940679e-02 | 1.532 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.451900e-02 | 1.462 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.783714e-02 | 1.422 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.476611e-02 | 1.459 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.200181e-02 | 1.495 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.555454e-02 | 1.449 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.940679e-02 | 1.532 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.940679e-02 | 1.532 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.940260e-02 | 1.532 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.952484e-02 | 1.403 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.989346e-02 | 1.399 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.989346e-02 | 1.399 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.990604e-02 | 1.399 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.990604e-02 | 1.399 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.990604e-02 | 1.399 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.025370e-02 | 1.395 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.031386e-02 | 1.395 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.031386e-02 | 1.395 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.031386e-02 | 1.395 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.031558e-02 | 1.395 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.043864e-02 | 1.393 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.043864e-02 | 1.393 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.225592e-02 | 1.374 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.230383e-02 | 1.374 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.230383e-02 | 1.374 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.257633e-02 | 1.371 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.316975e-02 | 1.365 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.349361e-02 | 1.362 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.450042e-02 | 1.352 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.465655e-02 | 1.350 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.488200e-02 | 1.348 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.668168e-02 | 1.331 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.772017e-02 | 1.321 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.893235e-02 | 1.310 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.893235e-02 | 1.310 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.893235e-02 | 1.310 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.896894e-02 | 1.310 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.897571e-02 | 1.310 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.987796e-02 | 1.302 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.987796e-02 | 1.302 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.033193e-02 | 1.298 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.106383e-02 | 1.292 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.106383e-02 | 1.292 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.106383e-02 | 1.292 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.106383e-02 | 1.292 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.106383e-02 | 1.292 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.106383e-02 | 1.292 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.256121e-02 | 1.279 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.256121e-02 | 1.279 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.256121e-02 | 1.279 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.256121e-02 | 1.279 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.270631e-02 | 1.278 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.327557e-02 | 1.273 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.350843e-02 | 1.272 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.413639e-02 | 1.267 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.449525e-02 | 1.264 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.461302e-02 | 1.263 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.526561e-02 | 1.258 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.550066e-02 | 1.256 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.566648e-02 | 1.254 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.566648e-02 | 1.254 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.566648e-02 | 1.254 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.753367e-02 | 1.240 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.753367e-02 | 1.240 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.753367e-02 | 1.240 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.753367e-02 | 1.240 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.753367e-02 | 1.240 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.753367e-02 | 1.240 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.772564e-02 | 1.239 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.772564e-02 | 1.239 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.772564e-02 | 1.239 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.937018e-02 | 1.226 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.076664e-02 | 1.216 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.080652e-02 | 1.216 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.080652e-02 | 1.216 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.088130e-02 | 1.216 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.088130e-02 | 1.216 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.092839e-02 | 1.215 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.092839e-02 | 1.215 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.092839e-02 | 1.215 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.171661e-02 | 1.210 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.175836e-02 | 1.209 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.187333e-02 | 1.208 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.187333e-02 | 1.208 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.229759e-02 | 1.206 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.229759e-02 | 1.206 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.264294e-02 | 1.203 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.595962e-02 | 1.181 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 9.912947e-02 | 1.004 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.912947e-02 | 1.004 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.912947e-02 | 1.004 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.630194e-02 | 1.178 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 6.630194e-02 | 1.178 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.630194e-02 | 1.178 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.630194e-02 | 1.178 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.630194e-02 | 1.178 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.630194e-02 | 1.178 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.630194e-02 | 1.178 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.630194e-02 | 1.178 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.630194e-02 | 1.178 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.630194e-02 | 1.178 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.630194e-02 | 1.178 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.630194e-02 | 1.178 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.630194e-02 | 1.178 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.690991e-02 | 1.014 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 9.690991e-02 | 1.014 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.408897e-02 | 1.130 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.408897e-02 | 1.130 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.152867e-02 | 1.146 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.321686e-02 | 1.080 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.584823e-02 | 1.018 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.660143e-02 | 1.015 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.556267e-02 | 1.122 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.660708e-02 | 1.062 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.584823e-02 | 1.018 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.850411e-02 | 1.164 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.404466e-02 | 1.027 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.556267e-02 | 1.122 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.556267e-02 | 1.122 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.539130e-02 | 1.069 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.660143e-02 | 1.015 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.710851e-02 | 1.113 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.953899e-02 | 1.048 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.659298e-02 | 1.177 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.305942e-02 | 1.081 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.710851e-02 | 1.113 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.863780e-02 | 1.163 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.710851e-02 | 1.113 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.621467e-02 | 1.179 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.120453e-02 | 1.147 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 7.408897e-02 | 1.130 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.408897e-02 | 1.130 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.758456e-02 | 1.011 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.168405e-02 | 1.038 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.041593e-02 | 1.152 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.804283e-02 | 1.167 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.100977e-02 | 1.149 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.860461e-02 | 1.105 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.849492e-02 | 1.053 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.152867e-02 | 1.146 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.660143e-02 | 1.015 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.356983e-02 | 1.078 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.869317e-02 | 1.052 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.869317e-02 | 1.052 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.617576e-02 | 1.118 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 9.417409e-02 | 1.026 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.404466e-02 | 1.027 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.509160e-02 | 1.070 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.702370e-02 | 1.113 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.869317e-02 | 1.052 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.869317e-02 | 1.052 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.869317e-02 | 1.052 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.850411e-02 | 1.164 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.305106e-02 | 1.081 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.702370e-02 | 1.113 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.931641e-02 | 1.003 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.931641e-02 | 1.003 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.006311e-01 | 0.997 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.006311e-01 | 0.997 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.028522e-01 | 0.988 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.034520e-01 | 0.985 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.045659e-01 | 0.981 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.045659e-01 | 0.981 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.045659e-01 | 0.981 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.045659e-01 | 0.981 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.066851e-01 | 0.972 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.066851e-01 | 0.972 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.070012e-01 | 0.971 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.072515e-01 | 0.970 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.072756e-01 | 0.969 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.080884e-01 | 0.966 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.080884e-01 | 0.966 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.080884e-01 | 0.966 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.080884e-01 | 0.966 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.090386e-01 | 0.962 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.093673e-01 | 0.961 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.093913e-01 | 0.961 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.093913e-01 | 0.961 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.093913e-01 | 0.961 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.094373e-01 | 0.961 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.107990e-01 | 0.955 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.130869e-01 | 0.947 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.141886e-01 | 0.942 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.144980e-01 | 0.941 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.172804e-01 | 0.931 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.179747e-01 | 0.928 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.179747e-01 | 0.928 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.179747e-01 | 0.928 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.198039e-01 | 0.922 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.212920e-01 | 0.916 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.216281e-01 | 0.915 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.216281e-01 | 0.915 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.218421e-01 | 0.914 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.218421e-01 | 0.914 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.218421e-01 | 0.914 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.218421e-01 | 0.914 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.220167e-01 | 0.914 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.234680e-01 | 0.908 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.234680e-01 | 0.908 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.238071e-01 | 0.907 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.238071e-01 | 0.907 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 1.238071e-01 | 0.907 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.265198e-01 | 0.898 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.273895e-01 | 0.895 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.291892e-01 | 0.889 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.295066e-01 | 0.888 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.306263e-01 | 0.884 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.306263e-01 | 0.884 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.306263e-01 | 0.884 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.306263e-01 | 0.884 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.306263e-01 | 0.884 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.306263e-01 | 0.884 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.308696e-01 | 0.883 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.320715e-01 | 0.879 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.320715e-01 | 0.879 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.320715e-01 | 0.879 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.320715e-01 | 0.879 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.320715e-01 | 0.879 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.341845e-01 | 0.872 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.341845e-01 | 0.872 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.349831e-01 | 0.870 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.349831e-01 | 0.870 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.368954e-01 | 0.864 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.368954e-01 | 0.864 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.368954e-01 | 0.864 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.382579e-01 | 0.859 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.383911e-01 | 0.859 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.383911e-01 | 0.859 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.383911e-01 | 0.859 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.390497e-01 | 0.857 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.390497e-01 | 0.857 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.390497e-01 | 0.857 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.390497e-01 | 0.857 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.390497e-01 | 0.857 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.397896e-01 | 0.855 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.397896e-01 | 0.855 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.412086e-01 | 0.850 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.415788e-01 | 0.849 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.884376e-01 | 0.725 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.884376e-01 | 0.725 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.884376e-01 | 0.725 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.884376e-01 | 0.725 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.884376e-01 | 0.725 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 2.688968e-01 | 0.570 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.688968e-01 | 0.570 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.688968e-01 | 0.570 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.688968e-01 | 0.570 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.688968e-01 | 0.570 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.665349e-01 | 0.778 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.665349e-01 | 0.778 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.665349e-01 | 0.778 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.038704e-01 | 0.691 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.561656e-01 | 0.806 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.419975e-01 | 0.616 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.419975e-01 | 0.616 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.589525e-01 | 0.799 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.803927e-01 | 0.552 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.803927e-01 | 0.552 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.803927e-01 | 0.552 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.803927e-01 | 0.552 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.803927e-01 | 0.552 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.803927e-01 | 0.552 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.790126e-01 | 0.747 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.790126e-01 | 0.747 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.349012e-01 | 0.629 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.349012e-01 | 0.629 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.718044e-01 | 0.765 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.718044e-01 | 0.765 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.487604e-01 | 0.828 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.487604e-01 | 0.828 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.213926e-01 | 0.655 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.780871e-01 | 0.749 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.780871e-01 | 0.749 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.071915e-01 | 0.684 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.660578e-01 | 0.575 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.259198e-01 | 0.646 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.580790e-01 | 0.801 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.640847e-01 | 0.578 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.640847e-01 | 0.578 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.240260e-01 | 0.650 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.838000e-01 | 0.547 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.838000e-01 | 0.547 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.598679e-01 | 0.585 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.771084e-01 | 0.752 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.633404e-01 | 0.579 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.779729e-01 | 0.556 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.748706e-01 | 0.561 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.998624e-01 | 0.699 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.240260e-01 | 0.650 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.078051e-01 | 0.682 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.487604e-01 | 0.828 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.631407e-01 | 0.787 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.814439e-01 | 0.741 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.926108e-01 | 0.715 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.598679e-01 | 0.585 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 2.889794e-01 | 0.539 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.541704e-01 | 0.812 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.259198e-01 | 0.646 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.470374e-01 | 0.833 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.631407e-01 | 0.787 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.665349e-01 | 0.778 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 2.625656e-01 | 0.581 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 2.889794e-01 | 0.539 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.773001e-01 | 0.751 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.300395e-01 | 0.638 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.503221e-01 | 0.823 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.472998e-01 | 0.832 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.980383e-01 | 0.703 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.698744e-01 | 0.569 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.884376e-01 | 0.725 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 1.665349e-01 | 0.778 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.038704e-01 | 0.691 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.803927e-01 | 0.552 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.631407e-01 | 0.787 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.569690e-01 | 0.804 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.095191e-01 | 0.679 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.942673e-01 | 0.712 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.391725e-01 | 0.621 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.391725e-01 | 0.621 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.773237e-01 | 0.557 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.773237e-01 | 0.557 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.669033e-01 | 0.574 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.703840e-01 | 0.568 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.209772e-01 | 0.656 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.349012e-01 | 0.629 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.718044e-01 | 0.765 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.808157e-01 | 0.743 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.174603e-01 | 0.663 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.038704e-01 | 0.691 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.814865e-01 | 0.741 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.092299e-01 | 0.679 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.127661e-01 | 0.672 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.450895e-01 | 0.611 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.863811e-01 | 0.543 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.550675e-01 | 0.809 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.434937e-01 | 0.614 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.926108e-01 | 0.715 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.859124e-01 | 0.544 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.213926e-01 | 0.655 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.631407e-01 | 0.787 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.495652e-01 | 0.825 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.884376e-01 | 0.725 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.688968e-01 | 0.570 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.803927e-01 | 0.552 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.349012e-01 | 0.629 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.213926e-01 | 0.655 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.213926e-01 | 0.655 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.838000e-01 | 0.547 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 1.741756e-01 | 0.759 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.720516e-01 | 0.565 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.277708e-01 | 0.643 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.863811e-01 | 0.543 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.088949e-01 | 0.680 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 1.847748e-01 | 0.733 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.942673e-01 | 0.712 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.300395e-01 | 0.638 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.803927e-01 | 0.552 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.803927e-01 | 0.552 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.660578e-01 | 0.575 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.427179e-01 | 0.615 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.598679e-01 | 0.585 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.598679e-01 | 0.585 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.779729e-01 | 0.556 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.738006e-01 | 0.563 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.540399e-01 | 0.812 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.807869e-01 | 0.552 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.158634e-01 | 0.666 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.255878e-01 | 0.647 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.589525e-01 | 0.799 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.902516e-01 | 0.721 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.038704e-01 | 0.691 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.419975e-01 | 0.616 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.892000e-01 | 0.723 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.245433e-01 | 0.649 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.434937e-01 | 0.614 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.942673e-01 | 0.712 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.906031e-01 | 0.537 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.814439e-01 | 0.741 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.348167e-01 | 0.629 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.561656e-01 | 0.806 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.718044e-01 | 0.765 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.598679e-01 | 0.585 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.892000e-01 | 0.723 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.814865e-01 | 0.741 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.419975e-01 | 0.616 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.803927e-01 | 0.552 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.045024e-01 | 0.689 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.453566e-01 | 0.838 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.390117e-01 | 0.622 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.038704e-01 | 0.691 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.803927e-01 | 0.552 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.790126e-01 | 0.747 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.550675e-01 | 0.809 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.770442e-01 | 0.557 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.589525e-01 | 0.799 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.889794e-01 | 0.539 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.598679e-01 | 0.585 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.863811e-01 | 0.543 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.889794e-01 | 0.539 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.995915e-01 | 0.700 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.240260e-01 | 0.650 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.589525e-01 | 0.799 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 2.906031e-01 | 0.537 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.998624e-01 | 0.699 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.660578e-01 | 0.575 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.928172e-01 | 0.533 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.928172e-01 | 0.533 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.950392e-01 | 0.530 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 2.974960e-01 | 0.527 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.991485e-01 | 0.524 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.009382e-01 | 0.522 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.037805e-01 | 0.517 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.037805e-01 | 0.517 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.037805e-01 | 0.517 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.038197e-01 | 0.517 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.078465e-01 | 0.512 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.121568e-01 | 0.506 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.129683e-01 | 0.504 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.129683e-01 | 0.504 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.142008e-01 | 0.503 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.160551e-01 | 0.500 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.160551e-01 | 0.500 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.185532e-01 | 0.497 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.186286e-01 | 0.497 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.186286e-01 | 0.497 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.186286e-01 | 0.497 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.186286e-01 | 0.497 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.186286e-01 | 0.497 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.186286e-01 | 0.497 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.186286e-01 | 0.497 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.186286e-01 | 0.497 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.188331e-01 | 0.496 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 3.188331e-01 | 0.496 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.188331e-01 | 0.496 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.189869e-01 | 0.496 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.189869e-01 | 0.496 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.189869e-01 | 0.496 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.239616e-01 | 0.490 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.239616e-01 | 0.490 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.257702e-01 | 0.487 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.257702e-01 | 0.487 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.297098e-01 | 0.482 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.354927e-01 | 0.474 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.354927e-01 | 0.474 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.355270e-01 | 0.474 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.355270e-01 | 0.474 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.383528e-01 | 0.471 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.394597e-01 | 0.469 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.410935e-01 | 0.467 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.413835e-01 | 0.467 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.413835e-01 | 0.467 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.413835e-01 | 0.467 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.413835e-01 | 0.467 | 0 | 0 |
| Essential pentosuria | R-HSA-5662853 | 3.413835e-01 | 0.467 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.413835e-01 | 0.467 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 3.413835e-01 | 0.467 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.413835e-01 | 0.467 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.442806e-01 | 0.463 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.442806e-01 | 0.463 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.470909e-01 | 0.460 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.470909e-01 | 0.460 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.470909e-01 | 0.460 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.492868e-01 | 0.457 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.492868e-01 | 0.457 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.492868e-01 | 0.457 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.492868e-01 | 0.457 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.521802e-01 | 0.453 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.563595e-01 | 0.448 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.563595e-01 | 0.448 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.563595e-01 | 0.448 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.563595e-01 | 0.448 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.563595e-01 | 0.448 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.563595e-01 | 0.448 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.563595e-01 | 0.448 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.563595e-01 | 0.448 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.563595e-01 | 0.448 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.563595e-01 | 0.448 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.588951e-01 | 0.445 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.588951e-01 | 0.445 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.588951e-01 | 0.445 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.604520e-01 | 0.443 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.620073e-01 | 0.441 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.675880e-01 | 0.435 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.675880e-01 | 0.435 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.683735e-01 | 0.434 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.689132e-01 | 0.433 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.752277e-01 | 0.426 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.752277e-01 | 0.426 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.804143e-01 | 0.420 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.822773e-01 | 0.418 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.822773e-01 | 0.418 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.850927e-01 | 0.414 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.850927e-01 | 0.414 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.850927e-01 | 0.414 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.850927e-01 | 0.414 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.850927e-01 | 0.414 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.850927e-01 | 0.414 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.933100e-01 | 0.405 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.933100e-01 | 0.405 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.933100e-01 | 0.405 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.933100e-01 | 0.405 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.933100e-01 | 0.405 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.031106e-01 | 0.395 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.031106e-01 | 0.395 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.031106e-01 | 0.395 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.042634e-01 | 0.393 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.042634e-01 | 0.393 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.054726e-01 | 0.392 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 4.054726e-01 | 0.392 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.055587e-01 | 0.392 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.055587e-01 | 0.392 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.066872e-01 | 0.391 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.066872e-01 | 0.391 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.066872e-01 | 0.391 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.066872e-01 | 0.391 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.066872e-01 | 0.391 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.088859e-01 | 0.388 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.127787e-01 | 0.384 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.172119e-01 | 0.380 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.196561e-01 | 0.377 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.257645e-01 | 0.371 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.257645e-01 | 0.371 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.257645e-01 | 0.371 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.286651e-01 | 0.368 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.286651e-01 | 0.368 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.286651e-01 | 0.368 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.286651e-01 | 0.368 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.286651e-01 | 0.368 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.292640e-01 | 0.367 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.292640e-01 | 0.367 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.292640e-01 | 0.367 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.292640e-01 | 0.367 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.292640e-01 | 0.367 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.292640e-01 | 0.367 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.292640e-01 | 0.367 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.306224e-01 | 0.366 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.306224e-01 | 0.366 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.306224e-01 | 0.366 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.306224e-01 | 0.366 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.315607e-01 | 0.365 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.360088e-01 | 0.361 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.360088e-01 | 0.361 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.360088e-01 | 0.361 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.419506e-01 | 0.355 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.459194e-01 | 0.351 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.485469e-01 | 0.348 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.515283e-01 | 0.345 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.515283e-01 | 0.345 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.515283e-01 | 0.345 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.515283e-01 | 0.345 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.515283e-01 | 0.345 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.515283e-01 | 0.345 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.526736e-01 | 0.344 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.576606e-01 | 0.339 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 4.576606e-01 | 0.339 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.576606e-01 | 0.339 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.576606e-01 | 0.339 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.576606e-01 | 0.339 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.588738e-01 | 0.338 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.588738e-01 | 0.338 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.640560e-01 | 0.333 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.640560e-01 | 0.333 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.640560e-01 | 0.333 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.640560e-01 | 0.333 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.640560e-01 | 0.333 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.655193e-01 | 0.332 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.655193e-01 | 0.332 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.655193e-01 | 0.332 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.655193e-01 | 0.332 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.655193e-01 | 0.332 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.655193e-01 | 0.332 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.655193e-01 | 0.332 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.655193e-01 | 0.332 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.655193e-01 | 0.332 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.655193e-01 | 0.332 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.658917e-01 | 0.332 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.658917e-01 | 0.332 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.692390e-01 | 0.329 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.740864e-01 | 0.324 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.768269e-01 | 0.322 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.768269e-01 | 0.322 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.780945e-01 | 0.320 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.841370e-01 | 0.315 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.841370e-01 | 0.315 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.841370e-01 | 0.315 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.841370e-01 | 0.315 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.841370e-01 | 0.315 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.841370e-01 | 0.315 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.841370e-01 | 0.315 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.841370e-01 | 0.315 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.853289e-01 | 0.314 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.856794e-01 | 0.314 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.856794e-01 | 0.314 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.931423e-01 | 0.307 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.946011e-01 | 0.306 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.962841e-01 | 0.304 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.975629e-01 | 0.303 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.975629e-01 | 0.303 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.975629e-01 | 0.303 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.975629e-01 | 0.303 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.019705e-01 | 0.299 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.019705e-01 | 0.299 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.043113e-01 | 0.297 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.051227e-01 | 0.297 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.051227e-01 | 0.297 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.051227e-01 | 0.297 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.078717e-01 | 0.294 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.078717e-01 | 0.294 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.099768e-01 | 0.292 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.099768e-01 | 0.292 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.099768e-01 | 0.292 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.121674e-01 | 0.291 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.180718e-01 | 0.286 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.180718e-01 | 0.286 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.180718e-01 | 0.286 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.180718e-01 | 0.286 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.180718e-01 | 0.286 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.185208e-01 | 0.285 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.185208e-01 | 0.285 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.185208e-01 | 0.285 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.185208e-01 | 0.285 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.185208e-01 | 0.285 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.185208e-01 | 0.285 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.185208e-01 | 0.285 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.185208e-01 | 0.285 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.185208e-01 | 0.285 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.185208e-01 | 0.285 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.185208e-01 | 0.285 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.185208e-01 | 0.285 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.187325e-01 | 0.285 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.243071e-01 | 0.280 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.296977e-01 | 0.276 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.296977e-01 | 0.276 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.296977e-01 | 0.276 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.296977e-01 | 0.276 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.296977e-01 | 0.276 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.296977e-01 | 0.276 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.342466e-01 | 0.272 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.351176e-01 | 0.272 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.351176e-01 | 0.272 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.394062e-01 | 0.268 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.413015e-01 | 0.267 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.431605e-01 | 0.265 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.595086e-01 | 0.252 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.604029e-01 | 0.251 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.604029e-01 | 0.251 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.604029e-01 | 0.251 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.604029e-01 | 0.251 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.604029e-01 | 0.251 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.604029e-01 | 0.251 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.606741e-01 | 0.251 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.616540e-01 | 0.251 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.633605e-01 | 0.249 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.662693e-01 | 0.247 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.662693e-01 | 0.247 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.662693e-01 | 0.247 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.662693e-01 | 0.247 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.662693e-01 | 0.247 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.662693e-01 | 0.247 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.662693e-01 | 0.247 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.662693e-01 | 0.247 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.662693e-01 | 0.247 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.662693e-01 | 0.247 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.662693e-01 | 0.247 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.662693e-01 | 0.247 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.662693e-01 | 0.247 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.662693e-01 | 0.247 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.662693e-01 | 0.247 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.671213e-01 | 0.246 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.698969e-01 | 0.244 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.797623e-01 | 0.237 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.798478e-01 | 0.237 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.804425e-01 | 0.236 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.813467e-01 | 0.236 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.813467e-01 | 0.236 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 5.831092e-01 | 0.234 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.849865e-01 | 0.233 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.849865e-01 | 0.233 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.849865e-01 | 0.233 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.849865e-01 | 0.233 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.954123e-01 | 0.225 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.974632e-01 | 0.224 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.003391e-01 | 0.222 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.003391e-01 | 0.222 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.056898e-01 | 0.218 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.058890e-01 | 0.218 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.058890e-01 | 0.218 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.058890e-01 | 0.218 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.063196e-01 | 0.217 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.092851e-01 | 0.215 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.092851e-01 | 0.215 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.092851e-01 | 0.215 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.092851e-01 | 0.215 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.092851e-01 | 0.215 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.092851e-01 | 0.215 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.092851e-01 | 0.215 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.092851e-01 | 0.215 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.092851e-01 | 0.215 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.092851e-01 | 0.215 | 0 | 0 |
| Metabolism of vitamin K | R-HSA-6806664 | 6.092851e-01 | 0.215 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.092851e-01 | 0.215 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.092851e-01 | 0.215 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.092851e-01 | 0.215 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.092851e-01 | 0.215 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.147375e-01 | 0.211 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.174152e-01 | 0.209 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.174152e-01 | 0.209 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.174152e-01 | 0.209 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.174152e-01 | 0.209 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.174152e-01 | 0.209 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.174152e-01 | 0.209 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.193452e-01 | 0.208 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.195362e-01 | 0.208 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.195362e-01 | 0.208 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.195362e-01 | 0.208 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.195362e-01 | 0.208 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.206855e-01 | 0.207 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.245080e-01 | 0.204 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.245080e-01 | 0.204 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.278256e-01 | 0.202 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.278256e-01 | 0.202 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.278256e-01 | 0.202 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.278256e-01 | 0.202 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.278256e-01 | 0.202 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.278256e-01 | 0.202 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.278256e-01 | 0.202 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.278256e-01 | 0.202 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.278256e-01 | 0.202 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.278256e-01 | 0.202 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.381431e-01 | 0.195 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.386106e-01 | 0.195 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.419404e-01 | 0.193 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.437149e-01 | 0.191 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.437149e-01 | 0.191 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.437149e-01 | 0.191 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.437149e-01 | 0.191 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.437149e-01 | 0.191 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.437149e-01 | 0.191 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.437149e-01 | 0.191 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.463211e-01 | 0.190 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.480370e-01 | 0.188 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.480370e-01 | 0.188 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.480370e-01 | 0.188 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.480370e-01 | 0.188 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.480370e-01 | 0.188 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.480370e-01 | 0.188 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.480370e-01 | 0.188 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.480370e-01 | 0.188 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.480370e-01 | 0.188 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.480370e-01 | 0.188 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.480370e-01 | 0.188 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.480370e-01 | 0.188 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.480370e-01 | 0.188 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.480370e-01 | 0.188 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.480370e-01 | 0.188 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.489048e-01 | 0.188 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.489048e-01 | 0.188 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.489048e-01 | 0.188 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.496204e-01 | 0.187 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.571775e-01 | 0.182 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.587986e-01 | 0.181 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.638520e-01 | 0.178 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.649087e-01 | 0.177 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.685637e-01 | 0.175 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.685637e-01 | 0.175 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.685637e-01 | 0.175 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 6.685637e-01 | 0.175 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.685637e-01 | 0.175 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.685637e-01 | 0.175 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.688037e-01 | 0.175 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.688037e-01 | 0.175 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.688037e-01 | 0.175 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.691191e-01 | 0.174 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.691191e-01 | 0.174 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.691191e-01 | 0.174 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.691191e-01 | 0.174 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.699992e-01 | 0.174 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.715356e-01 | 0.173 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.767662e-01 | 0.170 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.783878e-01 | 0.169 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.829474e-01 | 0.166 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.829474e-01 | 0.166 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.829474e-01 | 0.166 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.829474e-01 | 0.166 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.829474e-01 | 0.166 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.829474e-01 | 0.166 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.829474e-01 | 0.166 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.829474e-01 | 0.166 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.829474e-01 | 0.166 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.829474e-01 | 0.166 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.829474e-01 | 0.166 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.829474e-01 | 0.166 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.829474e-01 | 0.166 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.884672e-01 | 0.162 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.884672e-01 | 0.162 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.884672e-01 | 0.162 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.919904e-01 | 0.160 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.919904e-01 | 0.160 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.919904e-01 | 0.160 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.919904e-01 | 0.160 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.919904e-01 | 0.160 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.919904e-01 | 0.160 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.932335e-01 | 0.159 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.990775e-01 | 0.155 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.027027e-01 | 0.153 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.043315e-01 | 0.152 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.063865e-01 | 0.151 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.064583e-01 | 0.151 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.069531e-01 | 0.151 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.069531e-01 | 0.151 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.069531e-01 | 0.151 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.087007e-01 | 0.150 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.087007e-01 | 0.150 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.103674e-01 | 0.149 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.140327e-01 | 0.146 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.140327e-01 | 0.146 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.140327e-01 | 0.146 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.140327e-01 | 0.146 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.143971e-01 | 0.146 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.143971e-01 | 0.146 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.143971e-01 | 0.146 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.143971e-01 | 0.146 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.143971e-01 | 0.146 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.143971e-01 | 0.146 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.143971e-01 | 0.146 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.143971e-01 | 0.146 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.143971e-01 | 0.146 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.143971e-01 | 0.146 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.143971e-01 | 0.146 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.162371e-01 | 0.145 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.205636e-01 | 0.142 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.219873e-01 | 0.141 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.219873e-01 | 0.141 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.219873e-01 | 0.141 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.305240e-01 | 0.136 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.310816e-01 | 0.136 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.310816e-01 | 0.136 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.347347e-01 | 0.134 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.347347e-01 | 0.134 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 7.368984e-01 | 0.133 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.368984e-01 | 0.133 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.373969e-01 | 0.132 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.373969e-01 | 0.132 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.427288e-01 | 0.129 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.427288e-01 | 0.129 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.427288e-01 | 0.129 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.427288e-01 | 0.129 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.427288e-01 | 0.129 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.427288e-01 | 0.129 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.427288e-01 | 0.129 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.427288e-01 | 0.129 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.427288e-01 | 0.129 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.491749e-01 | 0.125 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.508468e-01 | 0.124 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.511969e-01 | 0.124 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.511969e-01 | 0.124 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.511969e-01 | 0.124 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.511969e-01 | 0.124 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.534944e-01 | 0.123 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.541453e-01 | 0.123 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.541453e-01 | 0.123 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.554544e-01 | 0.122 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.554544e-01 | 0.122 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.558875e-01 | 0.122 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.558875e-01 | 0.122 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.573310e-01 | 0.121 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.573310e-01 | 0.121 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.573433e-01 | 0.121 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.573433e-01 | 0.121 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.609346e-01 | 0.119 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.609346e-01 | 0.119 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.616201e-01 | 0.118 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.625091e-01 | 0.118 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.626216e-01 | 0.118 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.648906e-01 | 0.116 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.648906e-01 | 0.116 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.654026e-01 | 0.116 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.656820e-01 | 0.116 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.682515e-01 | 0.114 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.682515e-01 | 0.114 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.682515e-01 | 0.114 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.682515e-01 | 0.114 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.682515e-01 | 0.114 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.682515e-01 | 0.114 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.682515e-01 | 0.114 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 7.682515e-01 | 0.114 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.682515e-01 | 0.114 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.682515e-01 | 0.114 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.695616e-01 | 0.114 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.708523e-01 | 0.113 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.723170e-01 | 0.112 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.723170e-01 | 0.112 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.725037e-01 | 0.112 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.725037e-01 | 0.112 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.762224e-01 | 0.110 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.779887e-01 | 0.109 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.791569e-01 | 0.108 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.821448e-01 | 0.107 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.868791e-01 | 0.104 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.893044e-01 | 0.103 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 7.893044e-01 | 0.103 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.893044e-01 | 0.103 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.893044e-01 | 0.103 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.905025e-01 | 0.102 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.905025e-01 | 0.102 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.912436e-01 | 0.102 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.912436e-01 | 0.102 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.912436e-01 | 0.102 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.912436e-01 | 0.102 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.912436e-01 | 0.102 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.912436e-01 | 0.102 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.912436e-01 | 0.102 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.912436e-01 | 0.102 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.912436e-01 | 0.102 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.912436e-01 | 0.102 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.919008e-01 | 0.101 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.004926e-01 | 0.097 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.016175e-01 | 0.096 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.024444e-01 | 0.096 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.051638e-01 | 0.094 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.051638e-01 | 0.094 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.051638e-01 | 0.094 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.051638e-01 | 0.094 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.119558e-01 | 0.090 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.119558e-01 | 0.090 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.119558e-01 | 0.090 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.119558e-01 | 0.090 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.119558e-01 | 0.090 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.119558e-01 | 0.090 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.119558e-01 | 0.090 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.119558e-01 | 0.090 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.119558e-01 | 0.090 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.119558e-01 | 0.090 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.133689e-01 | 0.090 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.138281e-01 | 0.089 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.138281e-01 | 0.089 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.172801e-01 | 0.088 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.172801e-01 | 0.088 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.199515e-01 | 0.086 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.199515e-01 | 0.086 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.199515e-01 | 0.086 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.199515e-01 | 0.086 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.253344e-01 | 0.083 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.255336e-01 | 0.083 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.255336e-01 | 0.083 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.255336e-01 | 0.083 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.270457e-01 | 0.082 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.306141e-01 | 0.081 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.306141e-01 | 0.081 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.306141e-01 | 0.081 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.306141e-01 | 0.081 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.306141e-01 | 0.081 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.334232e-01 | 0.079 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.337242e-01 | 0.079 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.337242e-01 | 0.079 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.349801e-01 | 0.078 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.357725e-01 | 0.078 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.363834e-01 | 0.078 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.465375e-01 | 0.072 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.465375e-01 | 0.072 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.465375e-01 | 0.072 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.465375e-01 | 0.072 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.474221e-01 | 0.072 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.474221e-01 | 0.072 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.474221e-01 | 0.072 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.474221e-01 | 0.072 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.474221e-01 | 0.072 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.474221e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.474221e-01 | 0.072 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.474221e-01 | 0.072 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.474221e-01 | 0.072 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.474221e-01 | 0.072 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.474221e-01 | 0.072 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.474221e-01 | 0.072 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.474221e-01 | 0.072 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.538189e-01 | 0.069 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.538189e-01 | 0.069 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.540845e-01 | 0.068 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.540845e-01 | 0.068 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.592839e-01 | 0.066 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.622075e-01 | 0.064 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.625631e-01 | 0.064 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.625631e-01 | 0.064 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.625631e-01 | 0.064 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.625631e-01 | 0.064 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.625631e-01 | 0.064 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.625631e-01 | 0.064 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.625631e-01 | 0.064 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.625631e-01 | 0.064 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.625631e-01 | 0.064 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.625631e-01 | 0.064 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.625631e-01 | 0.064 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.625631e-01 | 0.064 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.625631e-01 | 0.064 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.629107e-01 | 0.064 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.630232e-01 | 0.064 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.652981e-01 | 0.063 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.676138e-01 | 0.062 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.695038e-01 | 0.061 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.695038e-01 | 0.061 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.762024e-01 | 0.057 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.762024e-01 | 0.057 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.762024e-01 | 0.057 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.762024e-01 | 0.057 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.762024e-01 | 0.057 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.762024e-01 | 0.057 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.762024e-01 | 0.057 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.762024e-01 | 0.057 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.762024e-01 | 0.057 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.762024e-01 | 0.057 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.791965e-01 | 0.056 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.791965e-01 | 0.056 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.797616e-01 | 0.056 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.835936e-01 | 0.054 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.850887e-01 | 0.053 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.884889e-01 | 0.051 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.884889e-01 | 0.051 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.884889e-01 | 0.051 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.884889e-01 | 0.051 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 8.884889e-01 | 0.051 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.884889e-01 | 0.051 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.884889e-01 | 0.051 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.892696e-01 | 0.051 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.892696e-01 | 0.051 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.909724e-01 | 0.050 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.937762e-01 | 0.049 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.980755e-01 | 0.047 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.995566e-01 | 0.046 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.995566e-01 | 0.046 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.995566e-01 | 0.046 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.995566e-01 | 0.046 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 8.995566e-01 | 0.046 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.995566e-01 | 0.046 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.995566e-01 | 0.046 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.995566e-01 | 0.046 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.062249e-01 | 0.043 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.062249e-01 | 0.043 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.064162e-01 | 0.043 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.074478e-01 | 0.042 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.095264e-01 | 0.041 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.095264e-01 | 0.041 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.095264e-01 | 0.041 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.095264e-01 | 0.041 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.095264e-01 | 0.041 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.139757e-01 | 0.039 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.164689e-01 | 0.038 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.183646e-01 | 0.037 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.183646e-01 | 0.037 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.185072e-01 | 0.037 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.185072e-01 | 0.037 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.185072e-01 | 0.037 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.185072e-01 | 0.037 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.185072e-01 | 0.037 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.193054e-01 | 0.037 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.207262e-01 | 0.036 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.207262e-01 | 0.036 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.207262e-01 | 0.036 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.221562e-01 | 0.035 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.236561e-01 | 0.034 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.241571e-01 | 0.034 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.242426e-01 | 0.034 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.244526e-01 | 0.034 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.256479e-01 | 0.034 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.265970e-01 | 0.033 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.265970e-01 | 0.033 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.265970e-01 | 0.033 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.265970e-01 | 0.033 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.271588e-01 | 0.033 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.271588e-01 | 0.033 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.286371e-01 | 0.032 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.286371e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.330959e-01 | 0.030 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.330959e-01 | 0.030 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.338841e-01 | 0.030 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.338841e-01 | 0.030 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.338841e-01 | 0.030 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.338841e-01 | 0.030 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.338841e-01 | 0.030 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.377281e-01 | 0.028 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.385726e-01 | 0.028 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.385726e-01 | 0.028 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.385726e-01 | 0.028 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.395423e-01 | 0.027 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.404482e-01 | 0.027 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.404482e-01 | 0.027 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.404482e-01 | 0.027 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.404482e-01 | 0.027 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.404482e-01 | 0.027 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.410699e-01 | 0.026 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.418816e-01 | 0.026 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.436218e-01 | 0.025 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.436218e-01 | 0.025 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.447293e-01 | 0.025 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.463609e-01 | 0.024 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.463609e-01 | 0.024 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.463609e-01 | 0.024 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.463609e-01 | 0.024 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.463609e-01 | 0.024 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.463609e-01 | 0.024 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.463609e-01 | 0.024 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.480384e-01 | 0.023 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.481821e-01 | 0.023 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.482743e-01 | 0.023 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.492836e-01 | 0.023 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.494009e-01 | 0.023 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.499711e-01 | 0.022 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.505854e-01 | 0.022 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.512353e-01 | 0.022 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.516869e-01 | 0.022 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.516869e-01 | 0.022 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.516869e-01 | 0.022 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.525591e-01 | 0.021 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.525591e-01 | 0.021 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.525591e-01 | 0.021 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.528218e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.528218e-01 | 0.021 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.564844e-01 | 0.019 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.564844e-01 | 0.019 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.564844e-01 | 0.019 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.565033e-01 | 0.019 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.568703e-01 | 0.019 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.588363e-01 | 0.018 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.595955e-01 | 0.018 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.601201e-01 | 0.018 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.608057e-01 | 0.017 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.608057e-01 | 0.017 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.608057e-01 | 0.017 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.625686e-01 | 0.017 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.625686e-01 | 0.017 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.646981e-01 | 0.016 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.646981e-01 | 0.016 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.646981e-01 | 0.016 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.665324e-01 | 0.015 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.665379e-01 | 0.015 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.682042e-01 | 0.014 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.682042e-01 | 0.014 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.694860e-01 | 0.013 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.704660e-01 | 0.013 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.705319e-01 | 0.013 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.713622e-01 | 0.013 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.727137e-01 | 0.012 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.727137e-01 | 0.012 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.736748e-01 | 0.012 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.742068e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.742068e-01 | 0.011 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.753556e-01 | 0.011 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.765065e-01 | 0.010 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.765065e-01 | 0.010 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.767312e-01 | 0.010 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.767689e-01 | 0.010 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.767689e-01 | 0.010 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.767689e-01 | 0.010 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.767790e-01 | 0.010 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.779018e-01 | 0.010 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.785088e-01 | 0.009 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.786774e-01 | 0.009 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.790767e-01 | 0.009 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.790767e-01 | 0.009 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.790767e-01 | 0.009 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.803452e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.803452e-01 | 0.009 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.811554e-01 | 0.008 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.820290e-01 | 0.008 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.829951e-01 | 0.007 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.830276e-01 | 0.007 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.833158e-01 | 0.007 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.854988e-01 | 0.006 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.856737e-01 | 0.006 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.862328e-01 | 0.006 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.862328e-01 | 0.006 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.862328e-01 | 0.006 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.862328e-01 | 0.006 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.864554e-01 | 0.006 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.868359e-01 | 0.006 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.870731e-01 | 0.006 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.871043e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.876009e-01 | 0.005 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.876009e-01 | 0.005 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.876009e-01 | 0.005 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.878394e-01 | 0.005 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.899428e-01 | 0.004 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.899428e-01 | 0.004 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.909424e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.911050e-01 | 0.004 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.911248e-01 | 0.004 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.912649e-01 | 0.004 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.912905e-01 | 0.004 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.912905e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.918426e-01 | 0.004 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.918426e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.920545e-01 | 0.003 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.926535e-01 | 0.003 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.926535e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.926535e-01 | 0.003 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.926535e-01 | 0.003 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.928695e-01 | 0.003 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.933835e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.933835e-01 | 0.003 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.933837e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.937492e-01 | 0.003 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.940415e-01 | 0.003 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.940415e-01 | 0.003 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.941879e-01 | 0.003 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.949813e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.956479e-01 | 0.002 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.968214e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.973811e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.974042e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.974042e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.976148e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.976148e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.978906e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.979095e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.979095e-01 | 0.001 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.985229e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.986253e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.987621e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.987647e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.989759e-01 | 0.000 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.990961e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.991860e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.992978e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.993204e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.994594e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.995408e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996482e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996685e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.997148e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.997432e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997432e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997556e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.997669e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997688e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.997926e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998156e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998312e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998316e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998337e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998435e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998629e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998756e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.998891e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999101e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999155e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999207e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999366e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999567e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999572e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999612e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999683e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999725e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999832e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999870e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999902e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999919e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999951e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999951e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999983e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999985e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999987e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999992e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999994e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999994e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999995e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999996e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999997e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |